During the three month period ended March 31, 2006, Providence was involved with the oil and gas servicing operations of PDX, finalizing the Securities Exchange Agreement and the Note Exchange Agreement, and the purchase of the Val Verde leases. Providence has realized revenues from providing servicing operations.
The following Results of Operations are based on the interim and annual financial statements prepared under US GAAP.
Providence expects to increase revenues within the next twelve months of operation subject to the successful realization of oil and gas production from its leasehold properties. However, Providence can provide no assurance that oil and gas exploration and development activities will ever produce revenue. Should Providence be unable to realize increase revenues, it will most likely continue to operate at a loss.
In the near term, Providence will not be able to generate sufficient cash flow from operations to sustain its business as lease development expenses increase and there can be no assurance that Providence will ever be able to generate sufficient cash flows to sustain operations. Providence’s business development strategy is prone to significant risks and uncertainties certain of which can have an immediate impact on its efforts to realize positive net cash flow and deter the prospect of revenue growth. Providence’s financial condition and results of operations will, in the near term, continue to depend on debt and equity financing from the Corporation or other related parties.
Revenue for the three month period ended March 31, 2006 was $348,142. Revenue for the year ended December 31, 2005 was $369,515. Revenue in both periods can be attributed to the provision of oil and gas services for third party operators in Texas and equipment sales.
Cost of goods sold for the three month period ended March 31, 2006 was $430,981. Cost of goods sold for the year ended December 31, 2005 was $694,382. Cost of goods sold in both periods can be primarily attributed to expenses associated with Providence’s oil and gas services. Cost of goods sold exceeded revenue because of high labor costs relating to the shortage of qualified personnel, equipment costs associated with the use of used equipment, and overhead costs associated with drilling operations. Providence intends to limit the provision of oil services in future periods.
Net losses for the three month period ended March 31, 2006, were $363,332. Net losses for the year ended December 31, 2005, were $778,764. The net losses in both periods can be primarily attributed to a cost of sales which exceeded revenues, general and administrative expenses, and an interest expense.
Providence may continue to operate at a loss through fiscal 2006 due to the nature of oil and gas exploration and development operations and Providence cannot determine whether it will ever generate significant revenues from operations.
Expenses
General and administrative expenses for the three month period ended March 31, 2006, were $182,532 and general and administrative expenses for the year ended December 31, 2005, were $278,131. General and administrative expenses can be primarily attributed to professional fees, depreciation, insurance, travel, and automobile expenses. Providence expects that general and administrative expenses will increase as Providence expands its operations.
Depreciation expenses for the three months ended March 31, 2006 were $39,780.
Depreciation expenses for the year ended December 31, 2005 were $62,049.
Capital Expenditures
Providence spent $2,376,117 on property and equipment for the three months ended March 31, 2006 and $4,410,161 for the year ended December 31, 2005, which capital expenditures included oil and gas properties, drilling rigs and equipment, office furniture and equipment, and automotive equipment.
Income Tax Expense (Benefit)
Providence has an income tax benefit resulting from net operating losses to offset any future operating profit.
Impact of Inflation
Providence believes that inflation has had an effect on operations since inception due to increased interest in oil and gas exploration which has increased prices for services and equipment. Providence believes that it can offset inflationary increases by improving operating efficiencies.
Liquidity and Capital Resources
Providence had current assets of $124,678 and total assets of $6,993,672 as of March 31, 2006. These assets included cash on hand of $11,259, promissory notes receivable totaling $82,322, oil and gas leases totaling $5,502,589, drilling rigs and equipment totaling $1,246,447, and other current, long term and other assets. Net member equity in Providence was $607,095 at March 31, 2006.
Providence had current assets of $134,342 and total assets of $4,643,353 as of December 31, 2005. These assets included cash on hand of $22,060, and oil and gas leases totaling $3,136,273, and drilling rigs and equipment totaling $1,236,647, and other current, long term and other assets. Net member equity in Providence was $243,764 at December 31, 2005.
Cash flows from operating activities were $494,678 for the three month period ended March 31, 2006, which included an accounts payable of $730,728, offsetting the net losses in the period. Cash flows used in operating activities were $590,916 for the period from inception until December 31, 2005, which included a net loss of $778,764.
Cash flows used in investing activities were $2,406,117 for the three month period ended March 31, 2006, which included the purchase of property and equipment totaling $2,376,117. Cash flows used in investing activities were $4,592,310 for the period from inception until December 31, 2005, which included the purchase of property and equipment totaling $4,410,161.
36
Cash flows from financing activities were $1,900,638 for the three month period ended March 31, 2006, comprised of notes payable of $1,982,320 less a payment against the notes of $81,862. Cash flows from financing activities were $5,205,286 for the period from inception until December 31, 2005, which included notes payable of $4,825,000.
The Corporation is committed to loan Providence up to $5,000,000 on a Secured Revolving Replacement Promissory Note (“Note”) to acquire oil, gas and mineral leasehold interests for exploration and development. The Corporation has advanced $4,207,320 to Providence pursuant to the Note as of March 30, 2006. The Note bears interest at 7% per annum and is to be paid in full by December 1, 2006. As of March 31, 2006, the Note had accrued interest of $75,726. The advances to Providence against the Note have been used (a) to acquire leasehold interests in Comanche, Hamilton and Val Verde Counties, (b) to fund initial exploratory work carried out by Providence’s joint venture operating partner, Harding Company, on the Comanche and Hamilton county leases, and (c) for general working capital.
Providence believes its current assets are insufficient to conduct its minimum plan of operation over the next twelve (12) months. No assurances can be given that additional funding as needed to explore and develop Providence’s lease interests will be available on acceptable terms or available at all. Providence’s inability to obtain funding would have a material adverse affect on Providence’s plan of operation.
Providence has no current plans for the purchase or sale of any plant or equipment.
Providence has no current plans to make any changes in the number of employees.
Going Concern
Providence’s audit expressed substantial doubt as to Providence’s ability to continue as a going concern as a result of insufficient revenue generating activities and a working capital deficit of $4,048,158 as of December 31, 2005, which increased to $6,013,413 at March 31, 2006. The continuation of Providence’s operations is dependent upon the continuing financial support of creditors and stockholders, obtaining short and long term financing, and achieving profitability. These conditions and dependencies raise substantial doubt about our ability to continue as a going concern.
Management’s plan to address Providence’s ability to continue as a going concern, include: (i) successfully developing oil and gas leases; (ii) obtaining additional debt financing on an inter-company basis to continue the development of its oil and gas leases; and (iii) transferring outstanding debt obligations to the Corporation as provided by the Note Exchange Agreement. The successful outcome of these activities cannot be determined at this time, and there is no assurance that, if achieved, that Providence would then have sufficient funds to execute its intended business plan or generate positive operating results.
37
PROPOSAL 3
APPROVAL OF AN AMENDMENT TO THE AMENDED AND RESTATED ARTICLES OF INCORPORATION TO INCREASE AUTHORIZED SHARES FROM 50,000,000 TO100,000,000
Under our Amended and Restated Articles of Incorporation as currently in effect, there are 50,000,000 shares of common stock authorized for issuance. As of _________, 2006, __________ shares of common stock were issued and outstanding. We will require additional shares pursuant to the Securities Exchange Agreement and the Note Exchange Agreement by which we will issue the following: (i) 12,213,670 shares of common stock to Providence’s promissory note holders on a pro rata basis; and (ii) 4,286,330 shares of common stock to Providence’s membership unit holders on a pro rata basis.
Additional shares of common stock may also be needed in connection with: (i) equity financings; (ii) acquisitions of other companies, businesses or assets; (iii) establishing strategic partnerships or other business relationships; or (iv) other corporate purposes.
On April 10, 2006, our Board of Directors approved an amendment to the first paragraph of Article Four of our Amended and Restated Articles of Incorporation to increase the shares of common stock that are authorized for issuance by 50,000,000 shares, bringing the total number of common shares authorized for issuance to 100,000,000. The directors also directed that the amendment be submitted for approval by the Corporation’s stockholders as required by Texas Business Corporation Act, Article 4.02. No change will be made to the number of shares of preferred stock that are authorized for issuance. The text of the proposed amendment to the first paragraph of Article IV of our Amended and Restated Articles of Incorporation is as follows:
“ARTICLE FOUR
| The total number of shares of stock which the corporation has authority to issue is One Hundred and Twenty Five Million (125,000,000) shares, of which One Hundred Million (100,000,000) shares shall be Common Stock, par value $0.0001 per share (the “Common Stock) and Twenty-Five Million (25,000,000) shares shall be Preferred Stock, par value $.0001 per share (the “Preferred Stock”). The corporation shall be entitled to treat the person in whose name any share of its stock is registered as the owner thereof for all purposes and shall not be bound to recognize any equitable or other claim to, or interest in, such share on the part of any other person, whether or not the corporation shall have notice thereof, except as expressly provided by applicable law. The shares of the Preferred Stock and Common Stock, respectively, shall have the following express terms:" |
If this proposal is approved by the stockholders at the Special Meeting, the Corporation will file an amendment to the Amended and Restated Articles of Incorporation for the purpose of increasing the authorized common stock. This amendment will become effective upon the filing of a Certificate of Amendment with the Secretary of State of Texas, which is expected to take place shortly after the Special Meeting.
The proposed increase in the authorized number of shares of common stock will not have any immediate effect on the rights of existing stockholders; however the issuance of a significant amount of common stock may, in the future, have a significant negative effect on the trading price of the common stock. Issuance of these shares may also substantially dilute the ownership interests of the Corporation’s existing stockholders.
38
Required Vote
Approval of this proposal requires the affirmative vote of the holders of a majority of the outstanding shares of Common Stock entitled to vote thereon at the meeting, assuming a quorum is present. Broker non-votes are counted solely for the purpose of determining a quorum. Abstentions will have the same effect as a vote against this proposal.
Board Recommendation
| | | | THE | | BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE “FOR” INCREASING THE AUTHORIZED SHARES OF COMMON STOCK FROM 50,000,000 TO 100,000,000. |
39
ADDITIONAL GENERAL INFORMATION
VOTING SECURITIES
As of _____________, 2006, there were _________ shares of the common stock and no shares of preferred stock issued and outstanding. Each holder of common stock is entitled to one vote for each share held by such holder.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth certain information concerning the ownership of the Corporation’s common stock as of __________, 2006, with respect to: (i) each person known to the Corporation to be the beneficial owner of more than five percent of the Corporation’s common stock; (ii) all directors; and (iii) directors and executive officers of the Corporation as a group.
- --------------------------------------------------------------------------------------------------
Title of Class Name and Address Number of Shares % of Class
- --------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------
Common Nora Coccaro, chief executive officer,
chief financial officer, director
1066 - 2610 West Hastings St. 353,500 _____
Vancouver, British Columbia
- --------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------
Common Markus Mueller, director 5,023,435 _____
Rossenweidstrasse 12 CH-8966 Zurich,
Switzerland
- --------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------
Common Global Convertible Megatrend Ltd. 1,445,465 _____
Bleicherweg 66 CH-8002
Zurich Switzerland
- --------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------
Common Nicolas Mathys
Weinberghohe 17 2,700,002 _____
6340 Baar, Switzerland
- --------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------
Common Officer and Directors as a Group 5,376,935 _____
- --------------------------------------------------------------------------------------------------
40
WHERE YOU CAN FIND MORE INFORMATION
The Corporation is subject to the informational requirements of the Securities Exchange Act of 1934, as amended. The Corporation files reports, proxy statements and other information with the Commission. The public may read and copy any materials that we file with the Commission at the Commission’s Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549. The public may obtain information on the operation of the Public Reference Room by calling 1-800-SEC-0330. The statements and forms we file with the Commission have been filed electronically and are available for viewing or copy on the Commission maintained Internet site that contains reports, proxy, and information statements, and other information regarding issuers that file electronically with the Commission. The Internet address for this site can be found at: www.sec.gov.
A copy of the Corporation’s yearly report on Form 10-KSB for the fiscal year ended December 31, 2005, can be found at the Commission’s Internet site. The yearly report does not form any part of the materials for the solicitation of proxies. Copies of the yearly report will be sent to any stockholder without charge upon written request addressed to: Healthbridge, Inc., 2610-1066 West Hastings Street, Vancouver, British Columbia V6E 3X2 Canada, attention: Corporate Secretary.
FINANCIAL STATEMENTS
The financial tables and notes that follow present the Corporation’s and Providence’s financial statements. The data hereto should be read together with the Corporation’s “Management’s Plan of Operation” and “Results of Operations” and Providence’s “Management’s Discussion and Analysis” and “Results of Operations” included in this proxy statement. The financial data for the years ended December 31, 2005 and 2004 are audited financial statements. The financial data for the three months ended March 31, 2006 and 2005 are unaudited, interim financial statements.
Description Page
Healthbridge, Inc., Financial Statements for the periods ended March 31, 2006 and 2005 FA-1
Healthbridge, Inc., Financial Statements for the years ended December 31, 2005 and 2004 FB-1
Providence Exploration, LLC, Financial Statements for the period ended March 31, 2006 FC-1
Providence Exploration, LLC, Financial Statements for the year ended December 31, 2005 FD-1
Healthbridge, Inc., Pro Forma - the period ended March 31, 2006 FE-1
- ---------------------------------------------------------------------------------------------------------------------------------------
Healthbridge, Inc., Pro Forma - the period ended December 31, 2005 FF-1
STOCKHOLDERS ARE URGED TO IMMEDIATELY MARK, DATE, SIGN AND RETURN THE ENCLOSED PROXY IN THE ENVELOPE PROVIDED. NON-U.S. SHAREHOLERS, PLEASE RETURN YOUR EXECUTED PROXY BY FAX TO INTERWEST TRANSFER, ATTN: STACY BANKS, AT (801) 272-3147. MS. BANK’S PHONE NUMBER IS (801) 272-9294.
41
HEALTHBRIDGE,
INC.
(A Development Stage Company)
INDEX
Page
Unaudited, Consolidated Balance Sheet as of March 31, 2006................................................FA-2
Unaudited, Consolidated Statement of Operations for the three month periods ended
March 31, 2006 and 2005 and the period from inception to March 31, 2006..............................FA-3
Unaudited, Consolidated Statement of Cash Flows for the three months ended March 31,
2006 and 2005 and the period from inception to March 31, 2006........................................FA-4
Notes to the Unaudited, Consolidated Financial Statements.................................................FA-5
FA-1
HEALTHBRIDGE, INC.
(A Development Stage Company)
CONSOLIDATED BALANCE SHEET
March 31, 2006
ASSETS
Current assets:
Cash $ 770,412
Promissory note receivable (including interest) 4,283,046
---------------------
Total current assets 5,053,458
Property and equipment, net -
---------------------
Total assets $ 5,053,458
=====================
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities:
Accounts payable $ 53,884
Accrued expenses 127,020
Related party payables 27,403
---------------------
Total current liabilities 208,307
---------------------
Convertible debentures 3,645,000
---------------------
Total Liabilities 3,853,307
---------------------
Stockholders' deficit:
Preferred stock, $.0001 par value, 25,000,000 shares
authorized, no shares issued and outstanding -
Common stock, $.0001 par value, 50,000,000 shares
authorized,16,480,841 shares issued and outstanding 1,648
Additional paid-in capital 10,425,371
Accumulated other comprehensive income 18,219
Deficit accumulated during the development stage (9,245,087)
---------------------
Total stockholders' deficit 1,200,150
---------------------
Total liabilities and stockholders' deficit $ 5,053,458
=====================
The accompanying notes are an integral part of these financial statements.
FA-2
HEALTHBRIDGE, INC.
(A Development Stage Company)
CONSOLIDATED STATEMENTS OF OPERATIONS
Three months ended March 31, 2006 and 2005 and Cumulative Amounts
Three months ended March 31, Cumulative
2006 2005 Amounts
---------------- --------------- ----------------
General and administrative expenses $ 98,806 $ 36,029 $ 3,425,075
Loss from operations (98,806) (36,029) (3,425,075)
Other income (expense):
Interest expense (65,333) (8,049) (406,470)
Interest income 72,153 105 104,331
---------------- --------------- ----------------
Loss before provision for income taxes
and discontinued operations (91,987) (43,973) (3,727,215)
Provision for income taxes - - -
---------------- --------------- ----------------
Loss before discontinued operations (91,987) (43,973) (3,727,215)
Loss from discontinued operations, net of tax - (17,222) (3,407,279)
---------------- --------------- ----------------
Net loss before cumulative effect
of accounting change (91,987) (61,195) (7,134,494)
Cumulative effect of accounting change, net of tax - - (102,500)
---------------- --------------- ----------------
Net loss (91,987) $ (61,195) $ (7,236,994)
================ =============== ================
Other Comprehensive Income
Foreign currency translation adjustment 3,849 3,925 18,219
---------------- --------------- ----------------
$ (88,138) $ (57,270) $ (7,218,775)
Net Comprehensive Income (Loss)
================ =============== ================
Loss per share from Continuing Operations -
Basic and diluted $ (0.01) $ (0.01)
================ ===============
Net Loss per common share - basic and diluted $ (0.01) $ (0.01)
================ ===============
Weighted average common shares -
Basic and diluted 16,480,841 6,884,333
================ ===============
The accompanying notes are an integral part of these financial statements.
FA-3
HEALTHBRIDGE, INC.
(A Development Stage Company)
CONSOLIDATED STATEMENTS OF CASH FLOWS
Three months ended March 31, 2006 and 2005 and Cumulative Amounts
Three months ended March 31, Cumulative
2006 2005 Amounts
---------------- --------------- ---------------
Cash flows from operating activities:
Net loss $ (91,987) $ (61,195) $ (7,236,994)
Adjustments to reconcile net loss to net cash
used in operating activities:
Stock and stock option compensation expense - - 1,589,864
Depreciation and amortization 1,019 10,243 152,757
Discontinued operations - - 2,542,150
Gain on write-off of liabilities - - (96,270)
(Increase) decrease in:
Accounts receivable and prepaid expenses (58,825) (2,785) (69,922)
Increase (decrease) in:
Accounts payable (65,983) 11,371 553,123
Accrued expenses 65,317 7,259 358,544
Related party payables 13,903 (5,095) 127,715
---------------- --------------- ---------------
Net cash used in operating activities (136,555) (40,202) (2,079,033)
---------------- --------------- ---------------
Cash flows from investing activities:
Proceeds paid for promissory notes Receivable (1,132,320) - (4,207,320)
Acquisition of intangible assets - - (150,398)
Acquisition of property and equipment - - (3,740)
---------------- --------------- ---------------
Net cash used in investing activities (1,132,320) - (4,361,458)
---------------- --------------- ---------------
Cash flows from financing activities:
Proceeds from notes payable - - 692,999
Issuance of common stock - 75,000 3,081,233
Commissions paid to raise convertible debentures - - (41,673)
Proceeds from convertible debentures - - 3,654,173
Payments on notes payable - - (194,048)
---------------- --------------- ---------------
Net cash provided by financing activities - 75,000 7,192,684
---------------- --------------- ---------------
Change in accumulated other comprehensive income 3,849 3,925 18,219
---------------- --------------- ---------------
Net increase (decrease) in cash (1,265,026) 38,723 770,412
Cash, beginning of period 2,035,438 37,286 -
---------------- --------------- ---------------
Cash, end of period $ 770,412 $ 76,009 $ 770,412
================ =============== ===============
The accompanying notes are an integral part of these financial statements.
FA-4
HEALTHBRIDGE, INC. AND SUBSIDIARIES
(A Development Stage Company)
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2006
(Unaudited)
Note 1 — Organization and Summary of Significant Accounting Policies
Organization
The consolidated financial statements consist of Healthbridge, Inc. (“Healthbridge”) and its wholly owned subsidiary, Healthbridge AG (“Healthbridge AG”) (collectively “the Company”). Healthbridge was organized on February 17, 1993 (date of inception) under the laws of the State of Texas. Healthbridge AG was formed as a German subsidiary during 2002.
On January 25, 2002, the Company acquired certain patents related to the infectious medical waste sterilization and disposal technologies developed in Germany. After the acquisition the Company’s operations consisted primarily of (1) developing a marketing philosophy and market strategy, (2) pursuing and assembling a management team, and (3) obtaining sufficient working capital through loans from stockholders and debt and equity financing.
In 2005, the Company decided to discontinue all operations connected to the Valides® Modular Infectious Waste Disposal System and the Medides System due to the unsatisfactory level of revenue generated to date.
The Company is considered a development stage company as defined in SFAS No. 7.
On November 21, 2005, the Company announced that it had executed a letter of intent to acquire Providence Exploration, LLC (“Providence”), as a wholly owned subsidiary. The Company intends to acquire Providence and its wholly owned subsidiaries in a stock for ownership exchange. The Securities Agreement requires the exchange of 4,286,330 shares of the Company’s common stock for all 1,250,000 of the issued and outstanding membership units of Providence. The Company expects to close this transaction, subject to stockholder approval, on June 30, 2006. The closing is further conditioned upon the concurrent closing a Note Exchange Agreement and upon the Company’s commitment to loan Providence up to $5,000,000 of which approximately $4,200,000 has been loaned to date.
Providence is a private company, headquartered in Dallas, Texas, that intends to explore, develop and produce oil and gas from the Marble Falls and Barnett Shale formations in prospect specific areas of the Fort Worth basin. The Barnett Shale is the largest producing natural gas opportunity in Texas with an estimated twenty six trillion cubic feet (TCF) of gas. The formation underlies approximately sixteen counties including Comanche and Hamilton counties, where Providence has signed an agreement to purchase approximately 6,330 acres (about ten square miles) of oil and gas leases. Providence will retain a 90% working interest and its joint venture operating partner, Dallas-based Harding Company, will retain a 10% working interest and operations. Providence also owns and operates one drilling rig and two well service rigs based in Young County, Texas, to service the increasing demand in the exploration industry.
Principles of Consolidation
The consolidated financial statements include the accounts of Healthbridge and Healthbridge AG. All significant intercompany balances and transactions have been eliminated.
FA-5
HEALTHBRIDGE, INC. AND SUBSIDIARIES
(A Development Stage Company)
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2006
(Unaudited)
Note 1 — Organization and Summary of Significant Accounting Policies (continued)
Cash and Cash Equivalents
For purposes of the statement of cash flows, the Company considers all highly liquid investments with a maturity of three months or less to be cash equivalents.
Property and Equipment
Property and equipment are stated at cost less accumulated depreciation. Maintenance and repairs are charged to expense as incurred. Costs of major renewals or betterments are capitalized over the remaining useful lives of the related assets. Depreciation is computed by using the straight-line method. Equipment is depreciated over the assets estimated useful life which is determined to be five years. The cost of property disposed of and related accumulated depreciation is removed from the accounts at the time of disposal, and gain or loss is reflected in operations.
Intangible Assets
Costs associated with the acquisition of patents have been capitalized and are being amortized over their useful life of 10 years. These costs will also be reviewed quarterly by management for impairment and valuation. Such impairment will be reviewed from available information at the time such as projected cash flow analysis, sales orders and other information available to help management determine future realization of this asset. Management will write this intangible down to its net realizable value at the time of impairment appears to exist.
Long-Lived Assets
The Company evaluates its long-lived assets in accordance with SFAS No. 144, “Accounting for the Impairment of Long-Lived Assets”. Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that their net book value may not be recoverable. When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related asset or group of assets over their estimated useful lives against their respective carrying amounts. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets and is recorded in the period in which the determination was made.
Revenue Recognition
Revenue from product sales is generally recognized at the time the product is shipped and invoiced and collectibility is reasonably assured. The Company believes that revenue should be recognized at the time of shipment as title generally passes to the customer at the time of shipment. This policy meets the criteria of Staff Accounting Bulletin 101 in that there is persuasive evidence of an existing contract or arrangement, deliver has occurred, the price is fixed and determinable and the collectibility is reasonably assured.
FA-6
HEALTHBRIDGE, INC. AND SUBSIDIARIES
(A Development Stage Company)
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2006
(Unaudited)
Note 1 — Organization and Summary of Significant Accounting Policies (continued)
Income Taxes
Deferred income taxes are provided in amounts sufficient to give effect to temporary differences between financial and tax reporting, principally related to deferred start-up cost. For income tax purposes start-up costs are deferred until the Company begins generating revenue, at which time the costs begin being amortized.
Earnings Per Share
The numerator for the earnings per share calculation is the net loss for the period. The denominator is the weighted average number of shares outstanding during the period.
The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the period plus the common stock equivalents which would arise from the exercise or conversion of warrants, options and convertible securities, if any, using the treasury stock method. Common stock equivalents are not included in the diluted earnings per share calculation when their effect is antidilutive.
Earnings Per Share computation for Continuing operations:
March 31,
2006 2005
Numerator - (loss from continuing operations) $ (91,987) (43,973)
Denominator - weighted average
number of shares outstanding 16,480,841 6,884,333
Loss per share $ (0.01) $ (0.01)
Earnings Per Share computation from Discontinued Operations:
March 31,
2006 2005
Numerator - (loss from discontinued operations )$ (91,987) (61,195)
Denominator - weighted average
number of shares outstanding 16,480,841 6,884,333
Loss per share-discontinued operations $ (0.01) $ (0.01)
FA-7
HEALTHBRIDGE, INC. AND SUBSIDIARIES
(A Development Stage Company)
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2006
(Unaudited)
Note 1 — Organization and Summary of Significant Accounting Policies (continued)
Earnings Per Share (continued)
Earnings Per Share computation for Net Income:
March 31,
2006 2005
Numerator - (Net Loss ) $ (91,987) (61,195)
Denominator - weighted average
number of shares outstanding 16,480,841 6,884,333
Loss per share $ (0.01) $ (0.01)
Translation of Foreign Currencies
Assets and liabilities of the Company’s foreign subsidiary are translated into U.S. dollars at the applicable exchange rates at year-end. Net gains or losses resulting from the translation of the Company’s assets and liabilities are reflected as a separate component of stockholders’ equity. A negative translation impact on stockholders’ equity reflects a current relative U.S. dollar value higher than at the point in time that assets were actually acquired in a foreign currency. A positive translation impact would result from a U.S. Dollar weaker in value than at the point in time foreign assets were acquired.
Income and expense items are translated at the weighted average rate of exchange (based on when transactions actually occurred) during the year.
Stock-Based Compensation
At March 31, 2006, the Company has stock-based employee compensation plans, which are described in greater detail in Note 12. The Company accounts for those plans under the recognition and measurement principles of APB Opinion 25, “Accounting for Stock Issued to Employees”, and related Interpretations, and has adopted the disclosure provisions of SFAS 123 (R), “Share Based Payment.”
Had compensation cost for the Company’s stock option plan been determined based on the fair value at the grant date for awards consistent with the provisions of SFAS 123 (R), the Company’s net loss and loss per share would have been reduced to the pro forma amounts indicated below:
FA-8
HEALTHBRIDGE, INC. AND SUBSIDIARIES
(A Development Stage Company)
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2006
(Unaudited)
Note 1 — Organization and Summary of Significant Accounting Policies (continued)
Stock-Based Compensation (continued)
Three months ended
March 31,
2006 2005
Net loss as reported $ (91,987) $ (61,195)
Deduct:
Total stock-based employee compensation expense
determined under fair value based method for all
awards, net of related tax effects - -
Net loss pro forma $ (91,987) $ (61,195)
Loss per share - basic and diluted:
As reported $ (.01) $ (.01)
Pro forma $ (.01) $ (.01)
Concentration of Credit Risk
The Company maintains its cash in bank deposit accounts, which, at times, may exceed federally insured limits. At March 31, 2006, the Company had $770,412 in bank deposit accounts. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash and cash equivalents.
Use of Estimates in the Preparation of Financial StatementsThe preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Reclassifications
Certain amounts in the 2005 financial statements may have been reclassified to conform to the 2006 presentation.
FA-9
HEALTHBRIDGE, INC. AND SUBSIDIARIES
(A Development Stage Company)
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2006
(Unaudited)
Note 2 — Going Concern
As of March 31, 2006, the Company’s revenue generating activities have not generated sufficient funds for profitable operations, and the Company has incurred losses since inception. These factors raise substantial doubt about the Company’s ability to continue as a going concern.
Management intends to seek additional equity funding to expand marketing efforts and product development. The continuation of the Company is dependent upon achieving a profitable level of operations as well as obtaining further long-term financing. At March 31, 2006 the Company had $770,412 remaining to fund its operational costs. Management plans to raise $10,000,000 in additional funds by way of common stock and debenture offerings over the next twelve months to finance the operations and capital requirements of the Company over the next year. While the Company is expending its best efforts to achieve the above plans, there is no assurance that any such activity will generate sufficient funds for operations. As a result, the Company may not be able to continue operations due to lack of funds to pay employees and vendors, and would not have the ability to repay loans to stockholders, officers, and other note holders. This could result in the notes becoming immediately due which could cause the company to discontinue operations due to liens or litigation.
Note 3 – Promissory Note Receivable
As of March 31, 2006, the Company has advanced $4,207,320 to Providence in exchange for a secured revolving promissory note. The note is secured by the assets of Providence including all of the debtor’s rights, titles and interests in certain leases of oil, gas and mineral interests located in the Comanche and Hamilton counties of Texas. The face value of the note increases to match the amounts advanced by the Company, to a maximum value of $5,000,000. The note bears interest at 7.0% per annum and is to be paid in full by December 1, 2006. As of March 31, 2006, the accrued interest was $75,726.
Note 4 – Patents
In 2002, patents were obtained pursuant to an agreement whereby the Company executed an Intellectual Property Assignment and Sale Agreement (“Agreement”) with B.I.M.E. GmBH, a German corporation, and Hermann Esser and Eduard Kneifel, both German residents (“Sellers”), to acquire certain infectious medical waste sterilization and disposal technologies developed in Germany. The Agreement transfers to the Company the exclusive ownership of both the Valides® Modular Infectious Medical Waste Disposal System and the Medides System together with all the intellectual property, including the patents, patents pending, proprietary software and licenses required to manufacture, operate and market these technologies worldwide. The patents are being amortized over a definite ten year life commencing at the date of acquisition in 2002.
FA-10
HEALTHBRIDGE, INC. AND SUBSIDIARIES
(A Development Stage Company)
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2006
(Unaudited)
Note 4 – Patents (continued)
As of December 31, 2004, the gross carrying value of the patents was $404,446 and accumulated amortization was $121,334. In the first six months of 2005, the company recognized a further $20,222 of amortization on the patents. On June 30, 2005 the Company reviewed the carrying value of its patents and determined that the prospect of sales this year and future expected cashflow from sales of the Valides system were unknown. Therefore the Company determined that there was sufficient evidence to indicate that the carrying value of the patent asset was impaired. Pursuant to the Company’s determination, it wrote off the remaining unamortized balance of $262,890 of its capitalized cost.
Total consideration for the transaction was $404,446, representing $179,446 in cash consideration through notes payable and $225,000 in non-cash consideration through the issuance of 750,000 shares restricted common stock valued at the fair market value on the date of issuance. As of December 31, 2004, the Company had paid cash to the Sellers totaling $150,398 and had issued 750,000 shares of restricted common stock. In 2005, the Company paid the outstanding balance of the note payable in cash. As of December 31, 2005, the Company had no further obligations with regards to the patents.
Note 5 — Property and Equipment
Property and equipment consist of the following at March 31, 2006:
Equipment $ 3,740
Less accumulated depreciation (3,740)
Net Value $ -
Depreciation expense for the three months ended March 31, 2006 and 2005 was $1,019 and $10,243 respectively.
Note 6 – Convertible Debentures
Two convertible debentures were issued during 2002 (May 3, 2002-$75,000 and May 6, 2002-$250,000), bearing interest at 7.5% per annum, which mature in three years. The convertible debentures become immediately due and payable upon certain events of default unless waived by the lender. Interest on the principal amount was due annually on the anniversary date of the issue date. The conversion feature allowed the holder at any time to convert any unpaid amount of principal or interest at $5.00 per share for a period of three years from the date of issuance. In the event that the trading average price of the shares during 30 consecutive trading days is above 200% of the conversion price, conversion is enforced by the Company. Pursuant to the terms of the convertible debenture, the Company agrees to file a Registration Statement within 60 days of conversion with the U.S. Securities and Exchange Commission. The convertible debentures are secured by substantially all of the Company’s assets consisting of all tangible and intangible property, but not limited to procedures, instruments, devices, equipment, research, designs, registrations, licenses, trademarks, software, patents, patents pending, “know-how” expertise, all additions and replacements to such property and any other documentation related to the Valides® and Medides systems for sterilizing and disinfecting infectious waste.
On January 14, 2004, the conversion price of the two debentures was adjusted to $0.10 per share.
FA-11
HEALTHBRIDGE, INC. AND SUBSIDIARIES
(A Development Stage Company)
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2006
(Unaudited)
Note 6 – Convertible Debentures (continued)
The terms for these two convertible debentures were extended to May 3, 2008 and May 6, 2010, respectively pursuant to the terms of extension agreements dated March 31, 2005. The extension agreements require certain additional conditions related to the Company’s obligations as follows:
1. The interest payable on the convertible debentures, as of May 4, 2005, accrues at a rate of ten percent (10%) per annum payable on a quarterly basis with the initial quarterly interest payments due on September 30, 2005 and at the end of each quarter thereafter until repayment or conversion.
2. The right to convert the whole part or any part of the principal amounts and accrued interest into shares of the Company extends until May 3, 2008 and May 6, 2010 respectively.
3. Upon conversion or repayment of the principal amounts and accrued interest, the holders of the convertible debentures are entitled to a ten percent (10%) bonus on the amount due as of such date. The market value of this bonus on the date of the extension was recorded as financing expense of $32,500.
On October 3, 2005 the Company reached an agreement with the beneficiaries of these two outstanding debentures for payment of interest accrued to September 30, 2005. The Company issued 136,298 shares of common stock to Global Convertible Megatrend Ltd. for $13,629 owed, and 56,250 shares of common stock to Max Fugman for $5,625 owed. For the three months ended March 31, 2006, the Company recorded $8,014 as interest expense. Accrued interest and financing costs as at March 31, 2006 for these two debentures totaled $48,704.
On November 28, 2005, the company issued seven convertible debenture certificates for the total principal sum of $3,320,000 due in full with accrued and unpaid interest on November 30, 2010. The interest at a rate of 7.0% per annum is payable on a semi-annual basis with the initial payment due on June 1, 2006. The holders of the debentures has the right to convert all or part of the principal and accrued interest into common shares of the Company at $0.35 per share at any time prior to maturity. For the three months ended March 31, 2006, the Company recorded $57,304 as interest expense. Accrued interest as at March 31, 2006 for these seven debentures totaled $78,316.
The total value of the principal of the nine convertible debentures outstanding as of March 31, 2006 was $3,645,000. Repayment of this principle is due according to the following schedule:
Year Principal Repayment
2006 -
2007 -
2008 -
2009 -
2010 $ 3,645,000
FA-12
HEALTHBRIDGE, INC. AND SUBSIDIARIES
(A Development Stage Company)
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2006
(Unaudited)
Note 7 — Income Taxes
The difference between income taxes at statutory rates and the amount presented in the financial statements is a result of the following:
Three Months Ended
March 31, Cumulative
2006 2005 Amounts
Income tax benefit at statutory rate $ (318,000) $ (106,000) $ (2,422,000)
Change in valuation allowance 318,000 106,000 2,422,000
$ - $ - $ -
Deferred tax assets are as follows at March 31, 2006:
NOL Carry-forward $ 2,422,000
Valuation allowance (2,422,000)
$ -
The Company has incurred Net Operating Losses of approximately $9,200,000. These losses will be carried forward to offset future taxable income and expire beginning in 2014. However, realization of the future tax benefit of these carry-forwards is contingent on the Company’s ability to generate positive net operations. A valuation allowance has been recorded for the full amount of the deferred tax asset because it is more likely than not that the deferred tax asset will not be realized.
Note 8 — Related Party Transactions
The Company has entered into an agreement with Markus Mueller, a director of the Company for consulting services. The agreement has an automatic renewal provision unless terminated by either party. During the three months ended March 31, 2006 and 2005, the Company recognized consulting expense of $10,500 each quarter.
The Company has entered into an agreement with Nora Coccaro, the Company’s President, for consulting services. The agreement has an automatic renewal provision unless terminated by either party. During the three months ended March 31, 2006 and 2005, the Company recognized consulting expense of approximately $10,500 and $8,025 respectively.
Note 9 — Supplemental Cash Flow Information
During the year ended December 31, 2005, the Company issued 1,250,000 shares of common stock at $0.10 per share for a total of $125,000. The Company also issued 6,270,000 shares of common stock at $0.30 per share for a total of $1,881,000.
In connection with the offering of 6,270,000 shares common stock and $3,320,000 of convertible debentures during the year, a sales commission totaling 5% was authorized for payment to two individuals, comprising of 3% in cash and 2% in warrants to purchase 348,000 shares of Company common stock at $0.30 per share. The warrants granted have a fair market value totaling $191,400.
FA-13
HEALTHBRIDGE, INC. AND SUBSIDIARIES
(A Development Stage Company)
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2006
(Unaudited)
Note 9 — Supplemental Cash Flow Information (continued)
During the year ended December 31, 2005, the Company issued 2,334,841 shares of common stock for accounts payable of $201,212, and accrued interest of $32,038. An amount of $116,742 was recorded as a financing cost due to the premium of the prevailing market price at the time of issuance over the stated price in the share for debt swap.
Note 10 — Preferred Stock
The Company’s preferred stock may have such rights, preferences and designations and may be issued in such series as determined by the Board of Directors. No shares were issued and outstanding at March 31, 2006.
Note 11— Warrants
During 2005, in connection with the offering of 6,270,000 shares common stock and $3,320,000 of convertible debentures during the year, a sales commission was partially paid in warrants. The warrants are exercisable in whole or in part allowing the holders to purchase 348,000 shares at an exercise price of $0.30 before the expiry date of December 1, 2010. On the date granted, the fair market value of these warrants, totaling $191,400, consisted of $68,970 for warrants issued in connection with the common stock offering, and $122,430 for warrants issued in connection with the debenture offering. The value of the warrants issued in connection with the debenture offering was recorded as a financing expense.
At March 31, 2006, the Company had 348,000 warrants outstanding.
Note 12 — Stock Based Compensation
The Company has adopted the disclosure provisions of Statement of Financial Accounting Standards (SFAS) No. 123 (R), “Share Based Payment” as described in Note 1.
No stock options were granted in 2006 and 2005. No stock options were outstanding at March 31, 2006.
Note 13 — Reverse Common Stock Split
Effective August 25, 2003, the Company approved a 1-for-20 reverse common stock split. All common share amounts, common stock option amounts and per share information have been retroactively adjusted to reflect this common stock split in the accompanying financial statements.
Note 14 — Fair Value of Financial Instruments
The Company’s financial instruments consist of cash, accounts receivable, accounts payable and notes payable. The carrying amount of these items approximates fair value because of their short-term nature and the notes payable bear interest at the market interest rate.
FA-14
HEALTHBRIDGE, INC. AND SUBSIDIARIES
(A Development Stage Company)
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2006
(Unaudited)
Note 15 – Discontinued Operations
Effective December 31, 2000, the Company closed its offices in Dallas, Texas, and discontinued its operations relating to the marketing and distributing of its Redloc II waste disposal system because of its inability to generate revenues due to lack of successfully obtaining contracts for its product. The Company wrote off inventory in the amount of $40,395 in accordance with SFAS No. 121 “Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed Of.” During the fourth quarter of 2002, the Company wrote off approximately $103,000 in assumed liabilities and included in gain (loss) on discontinued operations for 2002 is a gain of $102,692, and included in cumulative amounts from inception to December 31, 2002, is a net loss of $2,893,157. There was no tax effect on this transaction due to the Company’s loss position.
Effective December 31, 2005, the Company discontinued all operations connected to the Valides® Modular Infectious Waste Disposal System and the Medides System due to the unsatisfactory level of revenue generated to date. In 2005, $299,248 was recorded as the loss on discontinued operations. Included in cumulative amounts from inception to December 31, 2005 is a net loss of $514,122. There was no tax effect on this transaction due to the Company’s loss position.
There was no impact of discontinued operations for the three months ended March 31, 2006.
Note 16 — Recent Accounting Pronouncements
In December 2004, FASB issued a revision to SFAS 123 (R) “Share-Based Payment”. This Statement is a revision of FASB Statement No. 123, Accounting for Stock-Based Compensation. This Statement supersedes APB Opinion No. 25, Accounting for Stock Issued to Employees, and its related implementation guidance. This Statement establishes standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments. This Statement focuses primarily on accounting for transactions in which an entity obtains employee services in share-based payment transactions. This Statement does not change the accounting guidance for share-based payment transactions with parties other than employees provided in Statement 123 as originally issued and EITF Issue No. 96-18, “Accounting for Equity Instruments That Are Issued to Other Than Employees for Acquiring, or in Conjunction with Selling, Goods or Services.” This Statement does not address the accounting for employee share ownership plans, which are subject to AICPA Statement of Position 93-6, Employers’ Accounting for Employee Stock Ownership Plans. The Company does not believe adoption of this revision will have a material impact on the Company’s consolidated financial statements.
FA-15
HEALTHBRIDGE, INC. AND SUBSIDIARIES
(A Development Stage Company)
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2006
(Unaudited)
Note 16 — Recent Accounting Pronouncements (continued)
In June 2005, the Financial Accounting Standards Board (“FASB”) issued Statement of Financial Accounting Standard No. 154, “Accounting Changes and Error Corrections, a replacement of APB Opinion No. 20, Accounting Changes, and FASB Statement No. 3, Reporting Accounting Changes in Interim Financial Statements” (“SFAS 154”). The Statement applies to all voluntary changes in accounting principle, and changes the requirements for accounting for and reporting of a change in accounting principle. SFAS 154 requires retrospective application to prior periods’ financial statements of a voluntary change in accounting principle unless it is impracticable. SFAS 154 requires that a change in method of depreciation, amortization, or depletion for long-lived, non-financial assets be accounted for as a change in accounting estimate that is affected by a change in accounting principle. Opinion 20 previously required that such a change be reported as a change in accounting principle. SFAS 154 is effective for accounting changes and corrections of errors made in fiscal years beginning after December 15, 2005. We do not believe this pronouncement will have a material impact in our financial results.
Note 17 – Subsequent Events
Subsequent to March 31, 2006, the Company plans to raise up to $10,000,000 through an equity financing. Units, comprised of ten common shares and five common share purchase warrants, will be sold for $6.00 each.
On April 10, 2006, the Company entered into a Securities Exchange Agreement (“Securities Agreement”) with Providence and the membership unit holders of Providence for the acquisition of Providence by the Company. On April 10, 2006, the Company entered into a Note Exchange Agreement (“Note Agreement”) with the holders of certain promissory notes issued by Providence whereby the Company intends to acquire the outstanding promissory notes from the note holders in exchange for 12,213,670 shares of the Company ‘s common stock, to be distributed to the note holders as detailed in the Note Agreement. The Company expects to close these transactions, subject to shareholder approval, on June 30, 2006. The closing is further conditioned upon simultaneous closing with the Securities Agreement.
On April 11, 2006, the Company issued 867,493 common shares to Max Fugman upon conversion of a debenture. The conversion extinguished $86,749 of debt consisting of $75,000 of principal repayment and $11,749 in accrued interest.
On April 26, the Company issued 300,000 common shares valued at $360,000 to Nora Coccaro for services rendered.
FA-16
HEALTHBRIDGE,
INC.
(A Development Stage Company)
INDEX
Page
Report of Chisholm, Bierwolf and Nilson, LLC..............................................................FB-2
Unaudited, Consolidated Balance Sheet as of December 31, 2005.............................................FB-3
Unaudited, Consolidated Statement of Operations for the years ended December 31,
2005 and 2004 and the period from....................................................................FB-4
Consolidated Statements of Stockholders' Equity (Deficit) for the period from
inception to December 31, 2005.......................................................................FB-5
Unaudited, Consolidated Statement of Cash Flows for the years ended December 31,
2005 and 2004 and the period from inception to December 31, 2005.....................................FB-9
Notes to the Unaudited, Consolidated Financial Statements.................................................FB-10
FB-1
Report of Independent Registered Public Accounting Firm
To the Stockholders and Board of DirectorsHealthbridge,
Inc.Vancouver,
BC Canada
We have audited the accompanying consolidated balance sheets of Healthbridge, Inc. as of December 31, 2005 and 2004 and the related consolidated statement of operations, stockholders’ equity and comprehensive income and cash flows for the years then ended. These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.
We conducted our audit in accordance with standards of the PCAOB (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, audits of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of Healthbridge, Inc. as of December 31, 2005 and 2004. and the consolidated results of their operations and their cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2, the Company’s recurring operating losses and lack of working capital raise substantial doubt about its ability to continue as a going concern. Management’s plans in regard to those matters are also described in Note 2. The financial statements do not include any adjustments that might result from outcome of this uncertainty.
/s/ Chisholm Bierwolf & Nilson, LLC
Chisholm, Bierwolf & Nilson, LLCBountiful,
Utah
February 8, 2006
FB-2
HEALTHBRIDGE, INC.
(A Development Stage Company)
CONSOLIDATED BALANCE SHEET
December 31, 2005
ASSETS
Current assets:
Cash $ 2,035,438
Promissory note receivable (including interest) 3,091,901
--------------------
Total current assets 5,127,339
Property and equipment, net 1,019
Patents, net of amortization -
--------------------
Total assets $ 5,128,358
====================
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities:
Accounts payable $ 119,867
Accrued expenses 61,703
Related party payables 13,500
Notes payable -
--------------------
Total current liabilities 195,070
--------------------
Convertible debentures 3,645,000
--------------------
Total Liabilities 3,840,070
--------------------
Stockholders' deficit:
Preferred stock, $.0001 par value, 25,000,000 shares
authorized, no shares issued and outstanding -
Common stock, $.0001 par value, 50,000,000 shares
authorized,16,480,906 shares issued and outstanding 1,648
Additional paid-in capital 10,425,371
Accumulated other comprehensive income 14,370
Deficit accumulated during the development stage (9,153,101)
--------------------
--------------------
Total stockholders' equity 1,288,288
--------------------
--------------------
Total liabilities and stockholders' deficit $ 5,128,358
====================
====================
See accompanying notes to financial statements
FB-3
HEALTHBRIDGE, INC.
(A Development Stage Company)
CONSOLIDATED STATEMENTS OF OPERATIONS
Years ended December 31, 2005 and 2004 and Cumulative Amounts
ended September 30, 2005 Cumulative
2005 2004 Amounts
-------------- --------------- --------------
General and administrative expenses 468,677 167,714 3,326,269
Loss from operations (468,677) (167,714) (3,326,269)
Other income (expense):
Interest expense (200,517) (45,209) (341,137)
Interest income 23,585 - 32,178
-------------- --------------- --------------
Loss before provision for income taxes
and discontinued operations (645,609) (212,923) (3,635,228)
Provision for income taxes - - -
-------------- --------------- --------------
Loss before discontinued operations (645,609) (212,923) (3,635,228)
Gain (loss) from discontinued operations, net of tax (299,248) (98,835) (3,407,279)
-------------- --------------- --------------
Net loss before cumulative effect
of accounting change (944,857) (311,758) (7,042,507)
Cumulative effect of accounting change, net of tax - - (102,500)
-------------- --------------- --------------
Net loss (944,857) $ (311,758) $ (7,145,007)
============== =============== ==============
Other Comprehensive Income
Foreign currency translation adjustment 9,057 5,313 14,370
-------------- --------------- --------------
Net Comprehensive Income (Loss) $ (935,800) $ (306,445) $ (7,130,637)
============== =============== ==============
Loss per share from Continuing Operations -
basic/diluted $ (0.08) $ (0.07)
============== ===============
Net Loss per common share - basic and diluted $ (0.12) $ (0.10)
============== ===============
Weighted average common shares -
basic and diluted 8,032,000 3,238,086
============== ===============
============== ===============
See accompanying notes to financial statements
FB-4
HEALTHBRIDGE, INC.
(A Developmental Stage Company)
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) AND COMPREHENSIVE INCOME
February 17, 1993 ( Date of Inception) to December 31, 2004
Deficit
Accumulated Accumulated
Additional Other During the
Preferred Stock Common Stock Paid-in Comprehensive Development
-------------------------- ---------------------------
Shares Amount Shares Amount Capital Income Stage Total
----------- ---------- ------------ ----------- ---------- -------------- --------------- -----------
Balance at February 17, 1993 (date of
inception) - $ - 60,000 $ 6 $ 1,194 $ - $ - $ 1,200
Net loss - - - - - - (200) (200)
----------- ---------- ------------ ----------- ---------- -------------- --------------- -----------
Balance at December 31, 1993 - - 60,000 6 1,194 - (200) 1,000
Net loss - - - - - - (240) (240)
----------- ---------- ------------ ----------- ---------- -------------- --------------- -----------
Balance at December 31, 1994 - - 60,000 6 1,194 - (440) 760
Net loss - - - - - - (240) (240)
----------- ---------- ------------ ----------- ---------- -------------- --------------- -----------
Balance at December 31, 1995 - - 60,000 6 1,194 - (680) 520
Net loss - - - - - - (240) (240)
----------- ---------- ------------ ----------- ---------- -------------- --------------- -----------
Balance at December 31, 1996 - - 60,000 6 1,194 - (920) 280
Issuance of common stock for cash - - 32,068 3 80,269 - - 80,272
Net loss - - - - - - (79,765) (79,765)
----------- ---------- ------------ ----------- ---------- -------------- --------------- -----------
Balance at December 31, 1997 - - 92,068 9 81,463 - (80,685) 787
Issuance of common stock for:
Services - - 6,500 1 12,999 - - 13,000
Cash - - 26,170 3 26,167 - - 26,170
Additional shares due to rounding
after stock split - - 300 1 (1) - - -
Net loss - - - - - - (36,896) (36,896)
----------- ---------- ------------ ----------- ---------- -------------- --------------- -----------
Balance at December 31, 1998 - - 125,038 14 120,628 - (117,581) 3,061
See accompanying notes to financial statements
FB-5
HEALTHBRIDGE, INC.
(A Developmental Stage Company)
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) AND COMPREHENSIVE INCOME (continued)
February 17, 1993 ( Date of Inception) to December 31, 2004
Balance forward, December 31, 1998 - - 125,038 14 120,628 - (117,581) 3,061
Rounding - - (38) - - - - -
Issuance of common stock for:
Cash - - 22,500 2 899,998 - - 900,000
Assets - - 128,012 13 1,020,452 - - 1,020,465
Net book value of Healthbridge, Inc. - - 20,500 2 (2) - - -
Dividends-in-kind - - 50,202 5 2,008,091 - (2,008,096) -
Debt - - 242,500 23 999,978 - - 1,000,001
Reverse acquisition with Healthbridge,
Inc.
and Wattmonitor, Inc. - - 147,500 15 798,046 - - 798,061
Common stock offering costs - - - - (105,000) - - (105,000)
Reverse acquisition, retirement of old
shares
of Wattmonitor, Inc. - - (147,500) (15) (915,627) - 117,581 (798,061)
Share adjustment for shares previously
issued - - 150 - - - - -
Net loss - - - - - - (3,196,076) (3,196,076)
------------ ----------- ---------- ------------ ----------- -------------- ---------------- --------------
Balance at December 31, 1999 - - 588,864 60 4,826,564 - (5,204,172) (377,549)
Issuance of common stock for:
Debt - - 34,950 4 349,496 - - 349,500
Services - - 11,000 1 71,199 - - 71,200
Cash - - 19,500 2 194,998 - - 195,000
Accounts payable - - 7,500 1 74,999 - - 75,000
Common stock offering costs - - - - (15,600) - - (15,600)
Stock option compensation expense - - - - 6,000 - - 6,000
Net loss - - - - - - (816,545) (816,545)
------------ ----------- ---------- ------------ ----------- -------------- ---------------- --------------
Balance at December 31, 2000 - - 661,814 67 5,507,656 - (6,020,717) (512,994)
See accompanying notes to financial statements
FB-6
HEALTHBRIDGE, INC.
(A Developmental Stage Company)
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) AND COMPREHENSIVE INCOME(continued)
February 17, 1993 ( Date of Inception) to December 31, 2004
Balance forward at December 31, 2000 - - 661,814 67 5,507,656 - (6,020,717) (512,994)
Issuance of common stock for:
Services - - 84,400 9 258,941 - - 258,950
Accounts payable - - 13,750 1 59,999 - - 60,000
Debt - - 41,603 4 249,614 - - 249,618
Net loss - - - - - - (422,008) (422,008)
----------- ----------- ----------- ----------- ----------- ------------ --------------- -------------
Balance at December 31, 2001 - - 801,567 81 6,076,210 - (6,442,725) (366,434)
Comprehensive loss:
Net loss - Restated - - - - - - (1,221,203) (1,221,203)
Other comprehensive loss -
cumulative foreign currency translation
adjustment - - - - - 4,869 - 4,869
-------------
Total comprehensive loss - Restated (1,216,334)
=============
Issuance of common stock for:
Intellectual property - - 37,500 4 224,996 - - 225,000
Services - - 143,000 14 806,086 - - 806,100
Accounts payable and services - - 5,000 1 10,999 - - 11,000
Stock option compensation expense - - - - 12,500 - - 12,500
----------- ----------- ----------- ----------- ----------- ------------ --------------- -------------
Balance at December 31, 2002 - - 987,067 99 7,130,791 4,869 (7,663,928) (528,169)
Comprehensive loss:
Net loss - Restated - - - - - - (232,560) (232,560)
Other comprehensive loss -
cumulative foreign currency translation
adjustment - - - - - (806) - (806)
-------------
Total comprehensive loss - Restated (233,366)
=============
Issuance of common stock for:
Cash - - 314,165 32 102,801 - - 102,833
Services 2,100 - 3,888 - - 3,888
Debt 1,537,048 154 475,583 - - 475,737
Common stock offering costs - - - - (2,000) - - (2,000)
Issuance of common stock options for
services - - - - 15,000 - - 15,000
Additional shares due to rounding after
reverse split - - 65 - - - - -
----------- ----------- ----------- ----------- ----------- ------------ --------------- -------------
Balance at December 31, 2003 - - 2,840,445 285 7,726,063 4,063 (7,896,488) (166,077)
See accompanying notes to financial statements
FB-7
HEALTHBRIDGE, INC.
(A Developmental Stage Company)
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) AND COMPREHENSIVE INCOME(continued)
February 17, 1993 ( Date of Inception) to December 31, 2004
Balance forward at December 31, 2003 - - 2,840,445 285 7,726,063 4,063 (7,896,488) (166,077)
Issuance of common stock for:
Debt conversion - - 2,735,555 273 197,673 - - 197,946
Services 1,050,000 105 80,395 80,500
Other comprehensive loss -
cumulative foreign currency
translation adjustment - - - - - 1,250 - 1,250
Net loss - - - - - - (311,757) (311,757)
------------ ----------- ---------- ----------- ----------- ------------- ---------------- -------------
Balance at December 31, 2004 - - 6,626,065 663 8,004,131 5,313 (8,208,245) (198,138)
Issuance of common stock for:
Cash - - 7,520,000 752 2,005,248 - - 2,006,000
Debt - - 2,334,841 233 349,992 - - 350,226
Issuance of warrants for finders fees - - - - 191,400 - - 191,400
Common stock offering costs - - - - (125,400) - - (125,400)
Other comprehensive loss -
cumulative foreign currency
translation adjustment - - - - - 9,057 - 9,057
Net loss for the period - - - - - - (944,857) (944,857)
------------ ----------- ---------- ----------- ----------- ------------- ---------------- -------------
Balance at December 31, 2005 - $ - $ 1,649 $ $ 14,370 $ (9,153,101) $ 1,288,288
16,480,906 10,425,371
See accompanying notes to financial statements
FB-8
HEALTHBRIDGE, INC.
(A Development Stage Company)
CONSOLIDATED STATEMENTS OF CASH FLOWS
Years ended December 31, 2005 and 2004 and Cumulative Amounts
Cumulative
2005 2004 Amounts
---------------- ---------------- ----------------
Cash flows from operating activities:
Net loss $ (944,857) (311,757) (7,145,007)
Adjustments to reconcile net loss to net cash
used in operating activities:
Stock and stock option compensation expense 416,226 - 1,589,864
Depreciation and amortization 491 41,199 151,738
Discontinued operations 299,248 - 2,542,150
Gain on write-off of liabilities 6,422 - (96,270)
(Increase) decrease in:
Accounts receivable and prepaid expenses (16,901) 122 (11,097)
Increase (decrease) in:
Accounts payable 53,756 6,775 619,106
Accrued expenses 50,197 45,865 293,227
Related party payables (97,438) 246,583 113,812
---------------- ---------------- ----------------
Net cash used in operating activities (232,857) 28,786 (1,942,479)
---------------- ---------------- ----------------
Cash flows from investing activities:
Proceeds paid for promissory notes Receivable (3,075,000) - (3,075,000)
Acquisition of intangible assets - - (150,398)
Acquisition of property and equipment - - (3,740)
---------------- ---------------- ----------------
Net cash used in investing activities (3,075,000) - (3,229,138)
---------------- ---------------- ----------------
Cash flows from financing activities:
Proceeds from notes payable - - 692,999
Issuance of common stock 2,006,000 - 3,081,233
Commissions paid to raise convertible debentures - - (41,673)
Proceeds from convertible debentures 3,320,000 - 3,654,173
Payments on notes payable (29,048) - (194,048)
---------------- ---------------- ----------------
Net cash provided by financing activities 5,296,952 - 7,192,684
---------------- ---------------- ----------------
Change in accumulated other comprehensive income 9,057 1,250 14,370
---------------- ---------------- ----------------
Net increase (decrease) in cash 1,998,152 30,036 2,035,438
Cash, beginning of period 37,286 7,250 -
---------------- ---------------- ----------------
Cash, end of period $ 2,035,438 37,286 2,035,438
================ ================ ================
See accompanying notes to financial statements
FB-9
HEALTHBRIDGE, INC. AND SUBSIDIARIES
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2006
(Unaudited)
Note 1 — Organization and Summary of Significant Accounting Policies
Organization
The consolidated financial statements consist of Healthbridge, Inc. (Healthbridge) and its wholly owned subsidiary, Healthbridge AG (Healthbridge AG) (collectively “the Company”). Healthbridge was organized on February 17, 1993 (date of inception) under the laws of the State of Texas. Healthbridge AG was formed as a German subsidiary during 2002.
On January 25, 2002, the Company acquired certain patents related to the infectious medical waste sterilization and disposal technologies developed in Germany. Since this time the Company’s operations have consisted primarily of (1) developing a marketing philosophy and market strategy, (2) pursuing and assembling a management team, and (3) obtaining sufficient working capital through loans from shareholders and debt and equity financing. Further, the Company is considered a development stage company as defined in SFAS No. 7.
In 2005, Healthbridge decided to discontinue all operations connected to the Valides® Modular Infectious Waste Disposal System and the Medides System due to the unsatisfactory level of revenue generated to date.
On November 21, 2005, the Company announced that it had executed a letter of intent to acquire Providence Exploration, LLC (“Providence”), as a wholly owned subsidiary.
Providence is a private company, headquartered in Dallas, Texas, that intends to explore, develop and produce oil and gas from the Marble Falls and Barnett Shale formations in prospect specific areas of the Fort Worth basin. The Barnett Shale is the largest producing natural gas opportunity in Texas with an estimated twenty six trillion cubic feet (TCF) of gas. The formation underlies approximately sixteen counties including Comanche and Hamilton counties, where Providence has signed an agreement to purchase approximately 6,330 acres (about ten square miles) of oil and gas leases. Providence will retain a 90% working interest and its joint venture operating partner, Dallas-based Harding Company, will retain a 10% working interest and operations. Providence also owns and operates one drilling rig and two well service rigs based in Young County, Texas, to service the increasing demand in the exploration industry.
Principles of Consolidation
The consolidated financial statements include the accounts of Healthbridge, Inc. and its wholly owned subsidiary. All significant intercompany balances and transactions have been eliminated.
Cash and Cash Equivalents
For purposes of the statement of cash flows, the Company considers all highly liquid investments with a maturity of three months or less to be cash equivalents.
FB-10
HEALTHBRIDGE, INC. AND SUBSIDIARIES
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2006
(Unaudited)
Note 1 — Organization and Summary of Significant Accounting Policies (continued)
Property and Equipment
Property and equipment are stated at cost less accumulated depreciation. Maintenance and repairs are charged to expense as incurred. Costs of major renewals or betterments are capitalized over the remaining useful lives of the related assets. Depreciation is computed by using the straight-line method. Equipment is depreciated over the assets estimated useful life which is determined to be five years. The cost of property disposed of and related accumulated depreciation is removed from the accounts at the time of disposal, and gain or loss is reflected in operations.
Intangible Assets
Costs associated with the acquisition of patents have been capitalized and are being amortized over their useful life of 10 years. These costs will also be reviewed quarterly by management for impairment and valuation. Such impairment will be reviewed from available information at the time such as projected cash flow analysis, sales orders and other information available to help management determine future realization of this asset. Management will write this intangible down to its net realizable value at the time of impairment appears to exist.
Long-Lived Assets
The Company evaluates its long-lived assets in accordance with SFAS No. 144, “Accounting for the Impairment of Long-Lived Assets”. Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that their net book value may not be recoverable. When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related asset or group of assets over their estimated useful lives against their respective carrying amounts. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets and is recorded in the period in which the determination was made.
Revenue Recognition
Revenue from product sales is generally recognized at the time the product is shipped and invoiced and collectibility is reasonably assured. The Company believes that revenue should be recognized at the time of shipment as title generally passes to the customer at the time of shipment. This policy meets the criteria of Staff Accounting Bulletin 101 in that there is persuasive evidence of an existing contract or arrangement, deliver has occurred, the price is fixed and determinable and the collectibility is reasonably assured.
Income Taxes
Deferred income taxes are provided in amounts sufficient to give effect to temporary differences between financial and tax reporting, principally related to deferred start-up cost. For income tax purposes start-up costs are deferred until the Company begins generating revenue, at which time the costs begin being amortized.
FB-11
HEALTHBRIDGE, INC. AND SUBSIDIARIES
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2006
(Unaudited)
Note 1 — Organization and Summary of Significant Accounting Policies (continued)
Earnings Per Share
The numerator for the earnings per share calculation is the net loss for the period. The denominator is the weighted average number of shares outstanding during the period.
The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the period plus the common stock equivalents which would arise from the exercise or conversion of warrants, options and convertible securities, if any, using the treasury stock method. Common stock equivalents are not included in the diluted earnings per share calculation when their effect is antidilutive.
Earnings Per Share computation for Continuing operations:
December 31,
2005 2004
Numerator - (loss from continuing operations) $ (645,609) (212,923)
Denominator - weighted average
number of shares outstanding 8,032,000 3,238,086
Loss per share $ (0.08) $ (0.07)
Earnings Per Share computation from Discontinued Operations:
December 31,
2005 2004
Numerator - (loss from discontinued operations) $ (299,248) (98,835)
Denominator - weighted average
number of shares outstanding 8,032,000 3,238,086
Loss per share-discontinued operations $ (0.04) $ (0.03)
Earnings Per Share computation for Net Income:
December 31,
2005 2004
Numerator - (Net Loss) $ (944,857) (311,758)
Denominator - weighted average
number of shares outstanding 8,032,000 3,238,086
Loss per share $ (0.12) $ (0.10)
FB-12
HEALTHBRIDGE, INC. AND SUBSIDIARIES
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2006
(Unaudited)
Note 1 — Organization and Summary of Significant Accounting Policies (continued)
Translation of Foreign Currencies
Assets and liabilities of the Company’s foreign subsidiary are translated into U.S. dollars at the applicable exchange rates at year-end. Net gains or losses resulting from the translation of the Company’s assets and liabilities are reflected as a separate component of stockholders’ equity. A negative translation impact on stockholders’ equity reflects a current relative U.S. Dollar value higher than at the point in time that assets were actually acquired in a foreign currency. A positive translation impact would result from a U.S. Dollar weaker in value than at the point in time foreign assets were acquired.
Income and expense items are translated at the weighted average rate of exchange (based on when transactions actually occurred) during the year.
Stock-Based Compensation
At December 31, 2005, the Company has stock-based employee compensation plans, which are described more fully in Note 11. The Company accounts for those plans under the recognition and measurement principles of APB Opinion 25, “Accounting for Stock Issued to Employees”, and related Interpretations, and has adopted the disclosure provisions of SFAS 123 (R), “Share Based Payment.”
Had compensation cost for the Company’s stock option plan been determined based on the fair value at the grant date for awards consistent with the provisions of SFAS 123 (R), the Company’s net loss and loss per share would have been reduced to the pro forma amounts indicated below:
Years ended December 31,
2005 2004
Net loss as reported $ (795,615) $ (311,758)
Deduct:
Total stock-based employee compensation expense
determined under fair value based method for all
awards, net of related tax effects - -
Net loss pro forma $ (795,615) $ (311,758)
Loss per share - basic and diluted:
As reported $ (.10) $ (.10)
Pro forma $ (.10) $ (.10)
FB-13
HEALTHBRIDGE, INC. AND SUBSIDIARIES
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2006
(Unaudited)
Note 1 — Organization and Summary of Significant Accounting Policies (continued)
Concentration of Credit Risk
The Company maintains its cash in bank deposit accounts, which, at times, may exceed federally insured limits. At December 31, 2005, the Company had $2,035,438 in bank deposit accounts. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash and cash equivalents.
Use of Estimates in the Preparation of Financial StatementsThe preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Reclassifications
Certain amounts in the 2004 financial statements have been reclassified to conform to the 2005 presentation.
Note 2 — Going Concern
As of December 31, 2005, the Company’s revenue generating activities have not generated sufficient funds for profitable operations, and the Company has incurred losses since inception. These factors raise substantial doubt about the Company’s ability to continue as a going concern.
Management intends to seek additional equity funding to expand marketing efforts and product development. The continuation of the Company is dependent upon achieving a profitable level of operations as well as obtaining further long-term financing. At December 31, 2005 the Company had $2,035,438 remaining to fund its operational costs. Management plans to raise $10,000,000 in additional funds by way of common stock and debenture offerings over the next twelve months to finance the operations and capital requirements of the Company in 2006. While the Company is expending its best efforts to achieve the above plans, there is no assurance that any such activity will generate sufficient funds for operations. As a result, the Company may not be able to continue operations due to lack of funds to pay employees and vendors, and would not have the ability to repay loans to shareholders, officers, and other note holders. This could result in the notes becoming immediately due which could cause the company to discontinue operations due to liens or litigation.
FB-14
HEALTHBRIDGE, INC. AND SUBSIDIARIES
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2006
(Unaudited)
Note 3 – Promissory Note Receivable
As of December 31, 2005, the Company has advanced $3,075,000 to Providence Exploration LLP in exchange for a secured revolving promissory note. The note is secured by the assets of Providence Exploration including all of the debtor’s rights, titles and interests in certain leases of oil, gas and mineral interests located in the Comanche and Hamilton counties of Texas. The face value of the note increases to match the amounts advanced by the Company, to a maximum value of $5,000,000. The note bears interest at 7.0% per annum and is to be paid in full by December 1, 2006. As of December 31, 2005, the accrued interest was $16,901.
Note 4 – Patents
In 2002, patents were obtained pursuant to an agreement whereby the Company executed an Intellectual Property Assignment and Sale Agreement (“Agreement”) with B.I.M.E. GmBH, a German corporation, and Hermann Esser and Eduard Kneifel, both German residents (“Sellers”), to acquire certain infectious medical waste sterilization and disposal technologies developed in Germany. The Agreement transfers to the Company the exclusive ownership of both the Valides® Modular Infectious Medical Waste Disposal System and the Medides System together with all the intellectual property, including the patents, patents pending, proprietary software and licenses required to manufacture, operate and market these technologies worldwide. The patents are being amortized over a definite ten year life commencing at the date of acquisition in 2002.
As of December 31, 2004, the gross carrying value of the patents was $404,446 and accumulated amortization was $121,334. In the first six months of 2005, the company recognized a further $20,222 of amortization on the patents. On June 30, 2005 the Company reviewed the carrying value of its patents and determined that the prospect of sales this year and future expected cashflow from sales of the Valides system were unknown. Therefore the Company determined that there was sufficient evidence to indicate that the carrying value of the patent asset was impaired. Pursuant to the Company’s determination, it wrote off the remaining unamortized balance of $262,890 of its capitalized cost.
Total consideration for the transaction was $404,446, representing $179,446 in cash consideration through notes payable and $225,000 in non-cash consideration through the issuance of 750,000 shares restricted common stock valued at the fair market value on the date of issuance. As of December 31, 2004, the Company had paid cash to the Sellers totaling $150,398 and had issued 750,000 shares of restricted common stock. In 2005, the Company paid the outstanding balance of the note payable in cash. As of December 31, 2005, the Company has no further obligations with regards to the patents.
Note 5 — Property and Equipment
Property and equipment consist of the following at December 31, 2005:
Equipment $ 3,740
Less accumulated depreciation (2,721)
Net Value $ 1,019
Depreciation expense for the years ended December 31, 2005 and 2004 was $491 and $753 respectively.
FB-15
HEALTHBRIDGE, INC. AND SUBSIDIARIES
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2006
(Unaudited)
Note 6 – Convertible Debentures
Two convertible debentures were issued during 2002 (May 3, 2002-$75,000 and May 6, 2002-$250,000), bearing interest at 7.5% per annum, which were to mature within three years. The convertible debentures become immediately due and payable upon certain events of default unless waived by the lender. Interest on the principal amount was due annually on the anniversary date of the issue date. The conversion feature allowed the holder at any time to convert any unpaid amount of principal or interest at $5.00 per share for a period of three years from the date of issuance. In the event that the trading average price of the shares during 30 consecutive trading days is above 200% of the conversion price, conversion is enforced by the Company. Pursuant to the terms of the convertible debenture, the Company agrees to file a Registration Statement within 60 days of conversion with the U.S. Securities and Exchange Commission. The convertible debentures are secured by substantially all of the Company’s assets consisting of all tangible and intangible property, but not limited to procedures, instruments, devices, equipment, research, designs, registrations, licenses, trademarks, software, patents, patents pending, “know-how” expertise, all additions and replacements to such property and any other documentation related to the Valides® and Medides systems for sterilizing and disinfecting infectious waste.
On May 6, 2005, the conversion price of the two debentures was adjusted to $0.10 per share.
The terms for these two convertible debentures were extended to May 3, 2008 and May 6, 2010, respectively pursuant to the terms of extension agreements dated March 31, 2005. The extension agreements require certain additional conditions related to the Company’s obligations as follows:
1. | The interest payable on the convertible debentures, as of May 4, 2005, accrues at a rate of ten percent (10%) per annum payable on a quarterly basis with the initial quarterly interest payments due on September 30, 2005 and at the end of each quarter thereafter until repayment or conversion. |
2. | The right to convert the whole part or any part of the principal amounts and accrued interest into shares of the Company extends until May 3, 2008 and May 6, 2010 respectively. |
3. | Upon conversion or repayment of the principal amounts and accrued interest, the holders of the convertible debentures are entitled to a ten percent (10%) bonus on the amount due as of such date. The market value of this bonus on the date of the extension was recorded as financing expense of $32,500. |
On October 3, 2005 the Company reached an agreement with the beneficiaries of these two outstanding debentures for payment of interest accrued to September 30, 2005. The Company issued 136,298 shares of common stock to Global Convertible Megatrend Ltd. for $13,629 owed, and 56,250 shares of common stock to Max Fugman for $5,625 owed. Accrued interest for these two debentures at December 31, 2005 was approximately $8,191 and is included in accrued expenses.
FB-16
HEALTHBRIDGE, INC. AND SUBSIDIARIES
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2006
(Unaudited)
Note 6 – Convertible Debentures (continued)
On November 28, 2005, the company issued seven convertible debenture certificates for the total principal sum of $3,320,000 due in full with accrued and unpaid interest on November 30, 2010. The interest at a rate of 7.0% per annum is payable on a semi-annual basis with the initial payment due on June 1, 2006. The holders of the debentures has the right to convert all or part of the principal and accrued interest into common shares of the Company at $0.35 per share at any time prior to maturity. Accrued interest for these seven debentures at December 31, 2005 was approximately $21,012 and is included in accrued expenses.
The total value of the principal of the nine convertible debentures outstanding as of December 31, 2005 was $3,645,000. Repayment of this principle is due according to the following schedule:
Year Principal Repayment
2006 -
2007 -
2008 -
2009 -
2010 $ 3,645,000
Note 7 — Income Taxes
The difference between income taxes at statutory rates and the amount presented in the financial statements is a result of the following:
Years End December 31,
Cumulative
2005 2004 Amounts
Income tax benefit at statutory rate $ (318,000) $ (106,000) $ (2,422,000)
Change in valuation allowance 318,000 106,000 2,422,000
$ - $ - $ -
Deferred tax assets are as follows at December 31, 2005:
NOL Carry-forward $ 2,422,000
Valuation allowance (2,422,000)
$ -
The Company has incurred Net Operating Losses of approximately $9,000,000. These losses will be carried forward to offset future taxable income and will expire beginning in 2014. However, realization of the future tax benefit of these carry-forwards is contingent on the Company’s ability to generate positive net operations. A valuation allowance has been recorded for the full amount of the deferred tax asset because it is more likely than not that the deferred tax asset will not be realized.
FB-17
HEALTHBRIDGE, INC. AND SUBSIDIARIES
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2006
(Unaudited)
Note 8 — Related Party Transactions
Related party payables consist of amounts due to Markus Mueller, a director of the Company. Mr. Mueller advanced the Company $184,680 during 2004, and was paid back $12,600 in cash (principal and interest) and $138,680 in common stock. On October 25, 2005 the Company reached an agreement with Markus Mueller for the swap of equity for the outstanding debt as of September 30, 2005. Under such agreement the Company issued 2,092,293 shares of common stock for the cancellation of $101,500 recognized to Mr. Mueller for consulting fees, $6,000 of a cash loan, $527 in interest, and €73,826(US$88,945) of a loan to Healthbridge AG and €10,174(US$12,257) in interest.
The Company has entered into an agreement with Markus Mueller, a director of the Company for consulting services. The agreement has an automatic renewal provision unless terminated by either party. During the years ended December 31, 2005 and 2004, the Company recognized consulting expense of approximately $42,000 each year.
The Company has entered into an agreement with Nora Coccaro, the Company’s President, for consulting services. The agreement has an automatic renewal provision unless terminated by either party. During the years ended December 31, 2005 and 2004, the Company recognized consulting expense of approximately $43,331 and $32,000 respectively.
Note 9 — Supplemental Cash Flow Information
During the year ended December 31, 2005, the Company issued 1,250,000 shares of common stock at $0.10 per share for a total of $125,000. The Company also issued 6,270,000 shares of common stock at $0.30 per share for a total of $1,881,000.
In connection with the offering of 6,270,000 shares common stock and $3,320,000 of convertible debentures during the year, a sales commission totaling 5% was authorized for payment to two individuals, comprising of 3% in cash and 2% in warrants to purchase 346,733 shares of Company common stock at $0.30 per share. The warrants granted have a fair market value totaling $191,400.
During the year ended December 31, 2005, the Company issued 2,334,841 shares of common stock for accounts payable of $201,212, and accrued interest of $32,038. An amount of $116,742 was recorded as a financing cost due to the premium of the prevailing market price at the time of issuance over the stated price in the share for debt swap.
During the year ended December 31, 2004, the Company issued 3,785,555 shares of common stock for accounts payable of $239,180, accrued interest of $39,265.
Actual amounts paid for interest and income taxes for the years ended December 31, 2005 and 2004 and the cumulative amounts are as follows:
Cumulative
2005 2004 Amounts
Interest $ 46,120 $ 45,209 $ 186,740
Income taxes $ - $ - $ -
FB-18
HEALTHBRIDGE, INC. AND SUBSIDIARIES
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2006
(Unaudited)
Note 10 — Preferred Stock
The Company’s preferred stock may have such rights, preferences and designations and may be issued in such series as determined by the Board of Directors. No shares were issued and outstanding at December 31, 2005.
Note 11 — Stock Options
The Company has stock option plans; which authorize the grant of stock options to eligible employees, directors, and other individuals to purchase up to an aggregate of 6,620,000 shares of common stock. All options granted under the plans are granted at current market value at date of grant, and may be exercised between one year and ten years following the date of grant. The plans are intended to advance the interest of the Company by attracting and ensuring the retention of competent directors, employees, and consultants, and to provide incentives to those individuals to devote their utmost efforts to the advancement of the Company. This plan has been subsequently closed, as no options are currently outstanding.
A schedule of the options outstanding is as follows:
Exercise
Number of Price Per
Options Share
Outstanding at January 1, 2003 25,000 $ 1.40
Granted 25,000 .05
Exercised (37,500) 1.40
Outstanding at December 31, 2003 12,500 .05
Granted - -
Exercised - -
Expired (12,500) -
Outstanding at December 31, 2004 and 2005 - $ -
Note 12 — Warrants
During 2005, in connection with the offering of 6,270,000 shares common stock and $3,320,000 of convertible debentures during the year, a sales commission was partially paid in warrants. The warrants are exercisable in whole or in part allowing the holders to purchase 346,733 shares at an exercise price of $0.30 before the expiry date of December 1, 2010. On the date granted, the fair market value of these warrants, totaling $191,400, consisted of $68,970 for warrants issued in connection with the common stock offering and $122,430 for warrants issued in connection with the debenture offering. The value of the warrants issued in connection with the debenture offering was recorded as a financing expense.
FB-19
HEALTHBRIDGE, INC. AND SUBSIDIARIES
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2006
(Unaudited)
Note 13 — Stock Based Compensation
The Company has adopted the disclosure provisions of Statement of Financial Accounting Standards (SFAS) No. 123 (R), “Share Based Payment” as described in Note 1.
No stock options were granted in 2005 and 2004. No stock options were outstanding at December 31, 2005.
Note 14 — Reverse Common Stock Split
Effective August 25, 2003, the Company approved a 1-for-20 reverse common stock split. All common share amounts, common stock option amounts and per share information have been retroactively adjusted to reflect this common stock split in the accompanying financial statements.
Note 15 — Fair Value of Financial Instruments
The Company’s financial instruments consist of cash, accounts receivable, accounts payable and notes payable. The carrying amount of these items approximates fair value because of their short-term nature and the notes payable bear interest at the market interest rate.
Note 16 – Discontinued Operations
Effective December 31, 2000, the Company closed its offices in Dallas, Texas, and discontinued its operations relating to the marketing and distributing of its Redloc II waste disposal system because of its inability to generate revenues due to lack of successfully obtaining contracts for its product. The Company wrote off inventory in the amount of $40,395 in accordance with SFAS No. 121 “Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed Of.” During the fourth quarter of 2002, the Company wrote off approximately $103,000 in assumed liabilities and included in gain (loss) on discontinued operations for 2002 is a gain of $102,692, and included in cumulative amounts from inception to December 31, 2002, is a net loss of $2,893,157. There was no tax effect on this transaction due to the Company’s loss position.
Effective December 31, 2005, the Company discontinued all operations connected to the Valides® Modular Infectious Waste Disposal System and the Medides System due to the unsatisfactory level of revenue generated to date. In 2005, $299,248 was recorded as the loss on discontinued operations. Included in cumulative amounts from inception to December 31, 2005 is a net loss of $514,122. There was no tax effect on this transaction due to the Company’s loss position.
FB-20
HEALTHBRIDGE, INC. AND SUBSIDIARIES
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2006
(Unaudited)
Note 17 — Recent Accounting Pronouncements
In December 2004, FASB issued a revision to SFAS 123 (R) “Share-Based Payment”. This Statement is a revision of FASB Statement No. 123, Accounting for Stock-Based Compensation. This Statement supersedes APB Opinion No. 25, Accounting for Stock Issued to Employees, and its related implementation guidance. This Statement establishes standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments. This Statement focuses primarily on accounting for transactions in which an entity obtains employee services in share-based payment transactions. This Statement does not change the accounting guidance for share-based payment transactions with parties other than employees provided in Statement 123 as originally issued and EITF Issue No. 96-18, “Accounting for Equity Instruments That Are Issued to Other Than Employees for Acquiring, or in Conjunction with Selling, Goods or Services.” This Statement does not address the accounting for employee share ownership plans, which are subject to AICPA Statement of Position 93-6, Employers’ Accounting for Employee Stock Ownership Plans. The Company does not believe adoption of this revision will have a material impact on the Company’s consolidated financial statements.
In June 2005, the Financial Accounting Standards Board (“FASB”) issued Statement of Financial Accounting Standard No. 154, “Accounting Changes and Error Corrections, a replacement of APB Opinion No. 20, Accounting Changes, and FASB Statement No. 3, Reporting Accounting Changes in Interim Financial Statements” (“SFAS 154”). The Statement applies to all voluntary changes in accounting principle, and changes the requirements for accounting for and reporting of a change in accounting principle. SFAS 154 requires retrospective application to prior periods’ financial statements of a voluntary change in accounting principle unless it is impracticable. SFAS 154 requires that a change in method of depreciation, amortization, or depletion for long-lived, non-financial assets be accounted for as a change in accounting estimate that is affected by a change in accounting principle. Opinion 20 previously required that such a change be reported as a change in accounting principle. SFAS 154 is effective for accounting changes and corrections of errors made in fiscal years beginning after December 15, 2005. We do not believe this pronouncement will have a material impact in our financial results.
In December 2004, FASB issued SFAS 153 “Exchanges of Non-monetary Assets—an amendment of APB Opinion No. 29". The guidance in APB Opinion No. 29, Accounting for Non-monetary Transactions, is based on the principle that exchanges of non-monetary assets should be measured based on the fair value of the assets exchanged. The guidance in that Opinion, however, included certain exceptions to that principle. This Statement amends Opinion 29 to eliminate the exception for non-monetary exchanges of similar productive assets and replaces it with a general exception for exchanges of non-monetary assets that do not have commercial substance. A non-monetary exchange has commercial substance if the future cash flows of the entity are expected to change significantly as a result of the exchange. The Company does not believe adoption of SFAS 153 will have any impact on the Company’s consolidated financial statements.
FB-21
HEALTHBRIDGE, INC. AND SUBSIDIARIES
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2006
(Unaudited)
Note 17 — Recent Accounting Pronouncements (continued)
In December 2004, FASB issued SFAS 152 “Accounting for Real Estate Time-Sharing Transactions—an amendment of FASB Statements No. 66 and 67". This Statement amends FASB Statement No. 66, Accounting for Sales of Real Estate, to reference the financial accounting and reporting guidance for real estate time-sharing transactions that is provided in AICPA Statement of Position (SOP) 04-2, Accounting for Real Estate Time-Sharing Transactions. This Statement also amends FASB Statement No. 67, Accounting for Costs and Initial Rental Operations of Real Estate Projects, to state that the guidance for (a) incidental operations and (b) costs incurred to sell real estate projects does not apply to real estate time-sharing transactions. The accounting for those operations and costs is subject to the guidance in SOP 04-2. This Statement is effective for financial statements for fiscal years beginning after June 15, 2005. The Company does not believe adoption of SFAS 152 will have any impact on the Company’s consolidated financial statements.
In November 2004, the FASB issued SFAS 151 “Inventory Costs—an amendment of ARB No. 43". This Statement amends the guidance in ARB No. 43, Chapter 4, “Inventory Pricing,” to clarify the accounting for abnormal amounts of idle facility expense, freight, handling costs, and wasted material (spoilage). Paragraph 5 of ARB 43, Chapter 4, previously stated that “. . . under some circumstances, items such as idle facility expense, excessive spoilage, double freight, and re-handling costs may be so abnormal as to require treatment as current period charges. . . .” This Statement requires that those items be recognized as current-period charges regardless of whether they meet the criterion of “so abnormal.” In addition, this Statement requires that allocation of fixed production overheads to the costs of conversion be based on the normal capacity of the production facilities. The provisions of this Statement shall be effective for inventory costs incurred during fiscal years beginning after June 15, 2005. The Company does not believe adoption of SFAS 151 will have any impact on the Company’s consolidated financial statements.
FB-22
PROVIDENCE EXPLORATION, LLC
(A Development Stage Company)
INDEX
Page
Unaudited, Consolidated Balance Sheet as of March 31, 2006................................................FC-2
Unaudited, Consolidated Statement of Operations for the three month period ended
March 31, 2006.......................................................................................FC-3
Unaudited, Consolidated Statement of Cash Flows for the three months ended
March 31, 2006.......................................................................................FC-4
Notes to the Unaudited, Consolidated Financial Statements.................................................FC-5
FC-1
PROVIDENCE EXPLORATION, LLC
CONSOLIDATED BALANCE SHEET
MARCH 31, 2006
ASSETS
CURRENT ASSETS
Cash 11,259
Accounts Receivable (net of allowance) 82,322
Prepaid expenses 31,098
-----------------------
124,678
-----------------------
PROPERTY AND EQUIPMENT
Oil and gas properties - undeveloped 5,502,589
Drilling rigs and equipment 1,246,447
Office furniture and equipment 9,746
Automotive equipment 27,495
-----------------------
6,786,278
Less accumulated depreciation (101,829)
-----------------------
6,684,449
-----------------------
OTHER ASSETS
Loan origination fees, net of amortization of 11,389 64,861
Advances and note receivable - long term (Note 3) 117,418
Deposits 2,266
-----------------------
184,545
-----------------------
6,993,672
-----------------------
LIABILITIES
CURRENT
Accounts payable 757,341
Accrued expenses 196,252
Short-term notes payable (Note 7) 4,832,320
Current portion of long term notes payable (Note 4) 352,178
-----------------------
6,138,091
LONG-TERM NOTES PAYABLE (Note 4) 1,462,676
-----------------------
7,600,767
-----------------------
MEMBER'S EQUITY
INITIAL CONTRIBUTION 535,000
ACCUMULATED DEFICIT (1,142,095)
-----------------------
(607,095)
-----------------------
6,993,672
-----------------------
The accompanying notes are an integral part of these financial statements.
FC-2
PROVIDENCE EXPLORATION, LLC
CONSOLIDATED STATEMENT OF INCOME AND MEMBER'S EQUITY
THREE MONTHS ENDED MARCH 31, 2006
SALES 348,142
COST OF SALES (430,981)
-------------------------
(82,839)
-------------------------
GENERAL AND ADMINISTRATIVE EXPENSES
Automobile 10,368
Amortization 6,354
Bank Charges 1,643
Consulting 6,500
Depreciation 39,780
Insurance 10,411
Office 7,388
Professional fees 84,555
Rent 7,753
Telephone 3,461
Travel and entertainment 3,775
Utilities 544
-------------------------
182,532
-------------------------
NET LOSS BEFORE OTHER INCOME (EXPENSES) (265,372)
OTHER INCOME (EXPENSES)
Interest and other income 35.68
Interest expense (97,996)
-------------------------
NET LOSS FOR THE PERIOD (363,332)
MEMBER'S EQUITY, BEGINNING OF PERIOD (243,764)
-------------------------
MEMBER'S EQUITY, END OF PERIOD (607,095)
-------------------------
The accompanying notes are an integral part of these financial statements.
FC-3
PROVIDENCE EXPLORATION, LLC
CONSOLIDATED STATEMENT OF CASH FLOWS
THREE MONTHS ENDED MARCH 31, 2006
CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss (363,332)
Adjustments to reconcile net loss to net cash
used by operating activities
Depreciation 39,780
Amortization 6,354
Changes in:
Accounts receivable and prepaid expenses (1,138)
Accounts payable 730,728
Accrued expenses 82,286
---------------------
494,678
---------------------
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment (2,376,117)
Issuance of notes receivable (30,000)
---------------------
(2,406,117)
---------------------
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable 1,982,320
Payments on notes payable (81,682)
---------------------
1,900,638
---------------------
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (10,801)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 22,060
---------------------
CASH AND CASH EQUIVALENTS, END OF PERIOD 11,259
---------------------
The accompanying notes are an integral part of these financial statements.
FC-4
PROVIDENCE EXPLORATION, LLCNOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2006
NOTE 1 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:
Organization
The Company was formed on July 12, 2005, under the Laws of the State of Texas as a Limited Liability Company.
The Company formed a wholly owned subsidiary, PDX Drilling 1, LLC (PDX), on July 12. PDX was formed to acquire drilling and service rigs for the purpose of drilling oil and gas wells in Texas. PDX acquired 3 oil drilling rigs during 2005 and began drilling operations for its customers.
The Company formed a wholly owned subsidiary, Providence Resources LLC, on September 1, 2005 to acquire leases in Texas for oil and gas exploration and development. During 2005 and 2006, Oil and Gas Leases were acquired, and will be developed in the year.
The Company is in the oil & gas drilling business and has incurred revenues from oil drilling services performed for other entities. The Company will begin drilling on its own oil and gas leases in the year.
Principles of Consolidation
The consolidated financial statements include the accounts of Providence Exploration, LLC, PDX Drilling 1, LLC and Providence Resources LLC. All material intercompany accounts and transactions have been eliminated in the consolidation of the entities.
Cash and Cash Equivalents
The Company considers cash in operating and money market accounts to be cash and cash equivalents for the statement of cash flows.
Accounts Receivable
The Company considers accounts receivable to be fully collectible; accordingly no allowance for doubtful accounts is required. When amounts become uncollectible, they are charged to operations when that determination is made. Using this direct write-off method does not materially differ from the allowance method.
Property and Equipment
Drilling and service rigs and equipment are recorded at cost and are depreciated over their estimated useful lives of ten years using the straight-line method. Office furniture and equipment and automotive equipment are recorded at cost and depreciated over their estimated useful lives of five to ten years using the straight-line method.
Upon sale or retirement of property and equipment the cost and related accumulated depreciation or depletion of the asset are removed from the Company’s accounts and gain or loss is recognized.
Expenditures for repair and maintenance are charged to expense as incurred.
FC-5
PROVIDENCE EXPLORATION, LLCNOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2006
Oil and Gas Leases Not Subject to Amortization
Oil and gas lease costs are recorded at cost and consist of 6,272.5 acres of land leases in North Eastern Texas in the Barnett Shale Formation. These leases are undeveloped at March 31, 2006, and accordingly no depletion is included in the accompanying consolidated financial statements. To March 31, 2006, the Company had paid $4,868,593 in cash for property leases.
The Company follows the full cost method of accounting for exploration and development of oil and gas properties whereby all costs in acquiring, exploring and developing properties are capitalized, including estimate of abandonment costs, net of estimated equipment salvage costs. The Company capitalized $633,996 in exploration costs during the first quarter of 2006. No costs related to production, general corporate overhead, or similar activities have been capitalized. At March 31, 2006 the Company only had capitalized costs of unproved properties acquired. Leasehold costs are depleted based on the units-of-production method based on estimated proved reserves. No proved reserves currently exist for the Company and therefore no depletion has been taken as of March 31. 2006.
In accordance with Statement of Financial Accounting Standards No. 144 “Accounting for the Impairment or Disposal of Long-Lived Assets”, the Company reviews its long-lived assets to be held and used, excluding proved oil and gas properties accounted for under the full cost method of accounting, whenever events or circumstances indicate that the carrying value of those assets may not be recoverable. An impairment loss is indicated if the sum of the expected future net cash flows is less than the carrying amount of the assets. In this circumstance, the Company recognizes an impairment loss for the amount by which the carrying amount of the asset exceeds the estimated fair value of the asset. The Company’s long-lived assets related to its proved oil and gas properties accounted for under the full cost method of accounting are prescribed by the Securities and Exchange Commission (Regulation S-X, Rule 4-10, “Financial Accounting and Reporting for Oil and Gas Producing Activities Pursuant to the Federal Securities Laws and the Energy Policy and Conservation Act of 1975”).
Fair Market Value of Financial Instruments
The estimated fair value of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses and other liabilities approximate their carrying amounts in the financial statements. The Company’s financial instruments include notes payable. The carrying value of notes payable approximates market value because the borrowing rate is similar to other financial instruments with similar terms.
Revenue Recognition
The Company generated revenues during 2005 from service fees generated from its drilling rigs. Revenues are recorded upon the completion of the services, with the existence of an agreement and where collectability is reasonably assured. Oil and natural gas production revenue will be recognized at the time and point of sale after the product has been extracted from the ground.
Intangible Assets
Loan origination fees are being amortized on a straight line basis over the 36 month term of the loans.
FC-6
PROVIDENCE EXPLORATION, LLCNOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2006
Income Taxes
The Company is organized as a Limited Liability Company (LLC) and is taxed for federal income tax purposes as a partnership. Accordingly, no federal income tax liability or expense is included in the accompanying financial statements. Income from the Company is taxed to the partners on their respective returns.
NOTE 2 — USE OF ESTIMATES IN PREPARATION OF FINANCIAL STATEMENTS:
The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
NOTE 3 – RELATED PARTY RECEIVABLE:
The Company made advances to a member during the three months ended March 31, 2006 totaling $30,000. The Company also has a note receivable from a member in the amount of $87,418. The note receivable is unsecured and bears interest at 4.25%. The note receivable and unpaid interest is due December 31, 2008.
NOTE 4 - LONG-TERM DEBT:
Note Payable - FAGEB AG, secured by drilling equipment, payable in
quarterly installments of $25,119 through July 31, 2008, including
interest at 12%.
$214,354
Note Payable - Global Convertible Megatrend LTD., secured by
drilling equipment, payable in quarterly installments of $50,238
through July 31, 2008, including interest at 12%.
428,713
Note Payable - FAGEB AG, secured by drilling equipment, payable in
quarterly installments of $37,722 through September 25, 2008,
including interest at 12%. 321,787
Total 964,854
Less current portion 352,178
Long-term notes payable $ 613,676
NOTE 5 — MEMBERS’ CAPITAL:
Upon formation, the Members contributed $535,000 of capital to the Company.
FC-7
PROVIDENCE EXPLORATION, LLCNOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2006
NOTE 6 - SHORT TERM NOTES PAYABLE:
Notes payable - Swan Lake, unsecured, due December 31, 2006, plus
interest at 12 %, convertible into equity at $1.00 per share.
$350,000
Notes payable - Carerra, unsecured, due January 31, 2006, plus
interest at 12 %, convertible into equity at $1.00 per share.
150,000
Notes payable - Carrera, unsecured, due February 28, 2006, plus
interest at 12 %. 125,000
Notes payable - Healthbridge, Inc., secured by oil and
gas leases, due December 1, 2006, plus interest at 7 %.
(Note 8). 4,207,320
Total $4,832,320
NOTE 7 — PROPOSED TRANSACTION:
At December 31, 2005, the Company has a proposed transaction pending with Healthbridge, Inc., (a publicly owned Texas Corporation headquartered in Vancouver, B.C., Canada), whereby Healthbridge Inc. would acquire 100 percent ownership interest in the Company (including subsidiaries) in exchange for 16,500,000 shares of Healthbridge, Inc. common stock.
At March 31, 2006, Healthbridge Inc. has advanced the Company $4,207,320 to fund the purchase of the Company’s oil and gas leases.
NOTE 8 — AGREEMENT:
In October 2005, the Company signed a joint exploration agreement with Harding Company. Under the terms of the agreement, the Company and Harding Company intend to explore, develop and produce oil and gas from Marble Falls and Barnett Shale formations in targeted areas of the Ft. Worth basin. Harding Company is appointed as operator.
Providence is required pursuant to the agreement to fund 100% of all costs of the management and operation for a minimum of 3 wells. Providence will carry Harding for its 10% working interest in all wells drilled and completed through the pipeline connection phase, in the project.
NOTE 9 — COMMITMENTS AND CONTINGENCIES:
The Company leases office and warehouse space under an operating lease which expires October 1, 2007. The Company leases a vehicle under an operating lease which expires in October 2007.
Rent expense was $7,753 for the three months ended March 31, 2006. Automobile lease expense is included in automobile expense in the accompanying statement of income and members’ equity.
FC-8
PROVIDENCE EXPLORATION, LLCNOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2006
NOTE 10 – GOING CONCERN
As of March 31, 2006, the Company’s revenue generating activities have not generated sufficient funds for profitable operations, and the Company has a significant working capital deficit. These factors raise substantial doubt about the Company’s ability to continue as a going concern. Managements plan is to effect a merger with Healthbridge, Inc. subsequent to March 31, 2006, thus converting and eliminating the short-term and long term loans to equity in Healthbridge. Healthbridge will also assist in raising the needed funds for continued development of the oil & gas leases. If the merger does not occur, the company may not have sufficient funds to continue the development of its leases. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
NOTE 11 - SUPPLEMENTARY OIL AND GAS INFORMATION - FAS 69 (unaudited)The following unaudited disclosures on standardized measures of discounted cash flows and changes therein relating to proved oil and gas reserves are determined in accordance with United States Statements of Financial Accounting Standards No. 69 “Disclosures About Oil and Gas Producing Activities”.
Standardized Measure of Discounted Future Net Cash Flows and Changes Therein
In calculating the standardized measure of discounted future net cash flows, year-end constant prices and cost assumptions were applied to the Company’s annual future production from proved reserves to determine cash inflows. Future production and development costs are based on constant price assumptions and assume the continuation of existing economic, operating and regulatory conditions. Future income taxes are calculated by applying statutory income tax rates to future pre-tax cash flows after provision for the tax cost of oil and natural gas properties based upon existing laws and regulations. The discount was computed by application of a 10 percent discount factor to the future net cash flows. The calculation of the standardized measure of discounted future net cash flows is based upon discounted future net cash flows prepared by the Company’s independent qualified reserve evaluators in relation to the reserves they respectively evaluated, and adjusted by the Company to account for management’s estimate obligations and future income taxes. The Company cautions that the discounted future net cash flows relating to proved oil and gas reserves are an indication of neither the fair market value of the Company’s oil and gas properties, nor of the future net cash flows expected to be generated from such properties. The discounted future net cash flows do not include the fair market value of exploratory properties and probable or possible oil and gas reserves, nor is consideration given to the effect of anticipated future changes in crude oil and natural gas prices, development, asset retirement and production costs, and possible changes to tax and royalty regulations. The prescribed discount rate of 10 percent may not appropriately reflect future interest rates. The Company’s projections should not be interpreted as being equivalent to fair market value.
FC-9
PROVIDENCE EXPLORATION, LLCNOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2006
Net Proved Reserves (1, 2)
- ---------------------------------------- ----------------------- ------- ------------------------------------
Natural Gas Crude Oil and Natural Gas Liquids
(millions of cubic (thousands of barrels)
feet)
- ---------------------------------------- ----------------------- ------- ------------------------------------
- ---------------------------------------- ----------------------- ------- ------------------------------------
December 31, 2005 - -
- ---------------------------------------- ----------------------- ------- ------------------------------------
- ---------------------------------------- ----------------------- ------- ------------------------------------
Purchase of reserves in place - -
- ---------------------------------------- ----------------------- ------- ------------------------------------
- ---------------------------------------- ----------------------- ------- ------------------------------------
Production - -
- ---------------------------------------- ----------------------- ------- ------------------------------------
- ---------------------------------------- ----------------------- ------- ------------------------------------
Adjustment for uneconomic wells - -
- ---------------------------------------- ----------------------- ------- ------------------------------------
- ---------------------------------------- ----------------------- ------- ------------------------------------
March 31, 2006 - -
- ---------------------------------------- ======================= ------- ====================================
- ---------------------------------------- ======================= ------- ====================================
- ---------------------------------------- ----------------------- ------- ------------------------------------
- ---------------------------------------- ----------------------- ------- ------------------------------------
Developed - -
- ---------------------------------------- ----------------------- ------- ------------------------------------
- ---------------------------------------- ----------------------- ------- ------------------------------------
Undeveloped - -
- ---------------------------------------- ----------------------- ------- ------------------------------------
- ---------------------------------------- ----------------------- ------- ------------------------------------
Total - -
- ---------------------------------------- ======================= ------- ====================================
a. | | “Net” reserves are the remaining reserves of the Company, after deduction of estimated royalties and including royalty interests. |
b. | | “Proved oil and gas reserves.” Proved oil and gas reserves are the estimated quantities of crude oil, natural gas, and natural gas liquids which geological and engineering data demonstrate with reasonable certainty to be recoverable in future years from known reservoirs under existing economic and operating conditions, i.e., prices and costs as of the date the estimate is made. Prices include consideration of changes in existing prices provided only by contractual arrangements, but not on escalations based upon future conditions. |
i. | | Reservoirs are considered proved if economic product ability is supported by either actual production or conclusive formation test. The area of a reservoir considered proved includes that portion delineated by drilling and defined by gas-oil and /or oil-water contacts, if any; and the immediately adjoining portions not yet drilled, but which can be reasonably judged as economically productive on the basis of available geological and engineering data. In the absence of information on fluid contacts, the lowest known structural occurrence of hydrocarbons controls the lower proved limit of the reservoir. |
ii. | | Reserves which can be produced economically through application of improved recovery techniques (such as fluid injection) are included in the “proved” classification when successful testing by a pilot project, or the operation of an installed program in the reservoir, provides support for the engineering analysis on which the project or program was based. |
FC-10
PROVIDENCE EXPLORATION, LLCNOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2006
iii. Estimates of proved reserves do not include the following:
Oil that may become available from known reservoirs but is classified separately as “indicated additional reserves”;
| Crude oil, natural gas, and natural gas liquids, the recovery of which is subject to reasonable doubt because of uncertainty as to geology, reservoir characteristics, or economic factors; |
Crude oil, natural gas, and natural gas liquids, that may occur in undrilled prospects; and
| Crude oil, natural gas, and natural gas liquids, that may be recovered from oil shales, coal, gilsonite and other such sources. |
c. “Proved developed oil and gas reserves.” Proved developed oil and gas reserves are reserves that can be expected to be recovered through existing wells with existing equipment and operating methods. Additional oil and gas expected to be obtained through the application of fluid injection or other improved recovery techniques for supplementing the natural forces and mechanisms of primary recovery should be included as “proved developed reserves” only after testing by a pilot project or after the operation of an installed program has confirmed through production response that increased recovery will be achieved.
d. “Proved undeveloped reserves.” Proved undeveloped oil and gas reserves are reserves that are expected to be recovered from new wells on undrilled acreage, or from existing wells where a relatively major expenditure is required for recompletion. Reserves on undrilled acreage shall be limited to those drilling units offsetting productive unites that are reasonably certain of production when drilled. Proved reserves for other undrilled unites can be claimed only where it can be demonstrated with certainty that there is continuity of production from the existing productive formation. Under no circumstances should estimates, for proved undeveloped reserves be attributable to any acreage for which an application of fluid injection or other improved recovery technique is contemplated, unless such techniques have been proved effective by actual tests in the area and in the same reservoir.
(2) The Company does not file any estimates of total net proved crude oil or natural gas reserves with any U.S. federal authority or agency other than the SEC.
Standardized Measure of Discounted Future Net Cash Flows Related to Proved Oil and Gas Reserves
The company has no proved reserves and no oil and gas production and therefore has not presented the Standardized Measure of Discounted Future Net Cash Flows or operating results.
FC-11
PROVIDENCE EXPLORATION, LLCNOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2006
Capitalized Costs
- --------------------------------------------------------------------- ----------------- ---- ----------------
March 31, 2006 United States
- --------------------------------------------------------------------- ----------------- ---- ----------------
- --------------------------------------------------------------------- ----------------- ---- ----------------
Proved oil and gas properties $ -
- --------------------------------------------------------------------- ----------------- ---- ----------------
- --------------------------------------------------------------------- ----------------- ---- ----------------
Unproved oil and gas properties 4,868,593
- --------------------------------------------------------------------- ----------------- ---- ----------------
- --------------------------------------------------------------------- ----------------- ---- ----------------
Total capital costs 4,868,593
- --------------------------------------------------------------------- ----------------- ---- ----------------
- --------------------------------------------------------------------- ----------------- ---- ----------------
Accumulated depletion (-)
- --------------------------------------------------------------------- ----------------- ---- ----------------
- --------------------------------------------------------------------- ----------------- ---- ----------------
Net capitalized costs $ 4,868,593
- --------------------------------------------------------------------- ================= ---- ================
Costs Incurred
- -------------------------------------------------- ---------------- -- -----------------
United States
- -------------------------------------------------- ---------------- -- -----------------
- -------------------------------------------------- ---------------- -- -----------------
Three months ended March 31, 2005
- -------------------------------------------------- ---------------- -- -----------------
- -------------------------------------------------- ---------------- -- -----------------
Acquisitions:
- -------------------------------------------------- ---------------- -- -----------------
- -------------------------------------------------- ---------------- -- -----------------
Proved reserves $
-
- -------------------------------------------------- ---------------- -- -----------------
- -------------------------------------------------- ---------------- -- -----------------
Unproved reserves 1,523,320
- -------------------------------------------------- ---------------- -- -----------------
- -------------------------------------------------- ---------------- -- -----------------
Total acquisitions 1,523,320
- -------------------------------------------------- ---------------- -- -----------------
- -------------------------------------------------- ---------------- -- -----------------
Exploration costs -
- -------------------------------------------------- ---------------- -- -----------------
- -------------------------------------------------- ---------------- -- -----------------
Development costs -
- -------------------------------------------------- ---------------- -- -----------------
- -------------------------------------------------- ---------------- -- -----------------
Asset retirement obligations -
- -------------------------------------------------- ---------------- -- -----------------
- -------------------------------------------------- ---------------- -- -----------------
Total costs incurred $ 1,523,320
- -------------------------------------------------- ================ -- =================
NOTE 12 – SUBSEQUENT EVENTS
On April 10, 2006, Healthbridge, Inc., (“Healthbridge”) entered into a Securities Exchange Agreement (“Securities Agreement”) with Providence Exploration, LLC (“Providence”) and the membership unit holders of Providence. Providence is an oil and gas exploration company headquartered in Dallas, Texas with oil, gas and mineral lease hold interests in Comanche, Hamilton and Val Verde Counties, Texas.
Healthbridge intends to acquire Providence and its wholly owned subsidiaries in a stock for ownership exchange. The Securities Agreement requires the exchange of 4,286,330 shares of Healthbridge’s common stock for all 1,250,000 of the issued and outstanding membership units of Providence. Healthbridge expects to close this transaction, subject to shareholder approval, on June 9, 2006. The closing is further conditioned upon Healthbridge’s commitment to loan Providence up to $5,000,000 of which approximately $4,200,000 has been loaned to date.
On April 10, 2006, Healthbridge entered into a Note Exchange Agreement (“Note Agreement”) with the holders of certain promissory notes issued by Providence whereby Healthbridge intends to acquire the outstanding promissory notes from the note holders in exchange for 12,213,670 shares of Healthbridge’s common stock, to be distributed to the note holders as detailed in the Note Agreement. Healthbridge expects to close this transaction, subject to shareholder approval, on June 9, 2006. The closing is further conditioned upon simultaneous closing with the Securities Agreement.
FC-12
PROVIDENCE EXPLORATION,
LLC (A
Development Stage Company)
INDEX
Page
Report of Chisholm, Bierwolf and Nilson, LLC..............................................................FD-2
Unaudited, Consolidated Balance Sheet as of December 31, 2005.............................................FD-3
Unaudited, Consolidated Statement of Operations for the year ended December 31, 2005......................FD-5
Unaudited, Consolidated Statement of Cash Flows for the year ended December 31, 2005......................FD-6
Notes to the Unaudited, Consolidated Financial Statements.................................................FD-7
FD-1
Report of Independent Registered Public Accounting Firm
To the Stockholders and Board of DirectorsProvidence
Exploration, LLCDallas,
Texas
We have audited the accompanying consolidated balance sheet of Providence Exploration, LLC as of December 31, 2005 and the related consolidated statement of operations, stockholders’ equity and cash flows for the year then ended. These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audit.
We conducted our audit in accordance with standards of the PCAOB (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, audits of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of Providence Exploration, LLC as of December 31, 2005 and the consolidated results of their operations and their cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States of America.
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 11, the Company’s operating losses and lack of working capital raise substantial doubt about its ability to continue as a going concern. Management’s plans in regard to those matters are also described in Note 11. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
/s/ Chisholm, Bierwolf & Nilson, LLC
Chisholm, Bierwolf & Nilson, LLCBountiful,
Utah
April 11, 2006
FD-2
PROVIDENCE EXPLORATION, LLC.
CONSOLIDATED BALANCE SHEET
DECEMBER 31, 2005
CURRENT ASSETS:
Cash 22,060
Accounts receivable (net of allowance) 72,833
Note receivable (Note 3) 5,000
Prepaid expenses 34,449
------------------
------------------
Total current assets 134,342
------------------
------------------
PROPERTY AND EQUIPMENT:
Oil and gas leases - undeveloped 3,136,273
Drilling rigs and equipment 1,236,647
Office furniture and equipment 9,746
Automotive equipment 27,495
------------------
------------------
Total 4,410,161
Less accumulated depreciation (62,049)
------------------
------------------
Total property and equipment 4,348,112
------------------
------------------
OTHER ASSETS:
Loan origination fees, net of amortization of $5,035 71,215
Note receivable - long term (Note 3) 87,418
Deposits 2,266
------------------
------------------
Total other assets 160,899
------------------
------------------
Total assets 4,643,353
------------------
------------------
The accompanying notes are an integral part of the financial statements.
FD-3
PROVIDENCE EXPLORATION, LLC.
CONSOLIDATED BALANCE SHEET
DECEMBER 31, 2005
CURRENT LIABILITIES:
Accounts payable 26,615
Accrued expenses 113,966
Short term notes payable (Note 7) 3,700,000
Current portion of long term notes payable (Note 4) 341,919
-----------------
-----------------
Total current liabilities 4,182,500
LONG TERM NOTES PAYABLE (NOTE 4) 704,617
-----------------
Total liabilities 4,887,117
MEMBERS' EQUITY (243,764)
-----------------
Total liabilities and members' equity 4,643,353
-----------------
-----------------
The accompanying notes are an integral part of the financial statements.
FD-4
PROVIDENCE EXPLORATION, LLC.
CONSOLIDATED STATEMENT OF INCOME AND MEMBERS' EQUITY
FOR THE PERIOD JULY 12, 2005 (INCEPTION) THROUGH DECEMBER 31, 2005
SALES (NOTE 6) 369,515
----------------
COST OF SALES: 694,382
----------------
Gross profit (loss) (324,867)
----------------
----------------
GENERAL AND ADMINISTRATIVE EXPENSES
Automobile 4,710
Amortization 5,035
Bank charges 4,114
Consulting 8,000
Depreciation 62,049
Insurance 16,646
Office 15,792
Professional fees 91,151
Repairs and maintenance 1,070
Rent 6,429
Telephone 19,962
Travel and entertainment 41,945
Utilities 1,228
----------------
----------------
Total general and administrative expenses 278,131
Net loss before other income (expenses) (602,998)
OTHER INCOME (EXPENSES):
Interest and other income 38
Note receivable write off (89,731)
Interest expense (86,073)
----------------
----------------
Net loss (778,764)
MEMBERS' EQUITY, BEGINNING OF PERIOD 0
Capital contributions (Note 5) 535,000
----------------
----------------
MEMBERS' EQUITY, END OF PERIOD (243,764)
----------------
The accompanying notes are an integral part of the financial statements.
FD-5
PROVIDENCE EXPLORATION, LLC.
CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE PERIOD JULY 12, 2005 (INCEPTION) THROUGH DECEMBER 31, 2005
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss (778,764)
Adjustments to reconcile net loss to net cash
used by operating activities:
Depreciation 62,049
Amortization 5,035
Bad debt 89,731
Changes in:
Accounts receivable (72,833)
Prepaid expense (34,449)
Deposits (2,266)
Accounts payable 26,615
Accrued expenses 113,966
--------------------
--------------------
Net cash used by operating activities (590,916)
--------------------
--------------------
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment (4,410,161)
Issuance of notes receivable (182,149)
--------------------
--------------------
Net cash used by investing activities (4,592,310)
--------------------
--------------------
CASH FLOWS FROM FINANCING ACTIVITIES:
Capital contribution 535,000
Proceeds from notes payable 4,825,000
Payments on notes payable (78,464)
Loan origination fees (76,250)
--------------------
--------------------
Net cash provided by financing activities 5,205,286
--------------------
--------------------
Net increase in cash and cash equivalents 22,060
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 0
--------------------
CASH AND CASH EQUIVALENTS, END OF PERIOD 22,060
--------------------
SUPPLEMENTAL CASH FLOW INFORMATION:
Interest paid 30,061
--------------------
--------------------
The accompanying notes are an integral part of the financial statements.
FD-6
PROVIDENCE EXPLORATION, LLCNOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005
NOTE 1 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:
Organization
The Company was formed on July 12, 2005, under the Laws of the State of Texas as a Limited Liability Company.
The Company formed a wholly owned subsidiary, PDX Drilling 1, LLC (PDX), on July 12. PDX was formed to acquire drilling and service rigs for the purpose of drilling oil and gas wells in Texas. PDX acquired 3 oil drilling rigs during 2005 and began drilling operations for its customers.
The Company formed a wholly owned subsidiary, Providence Resources LLC, on September 1, 2005 to acquire leases in Texas for oil and gas exploration and development. During 2005 Oil and Gas Leases were acquired, and will be developed in the coming year.
The Company is in the oil & gas drilling business and has incurred revenues from oil drilling services performed for other entities. The Company will begin drilling on its own oil and gas leases in the coming year.
Principles of Consolidation
The consolidated financial statements include the accounts of Providence Exploration, LLC, PDX Drilling 1, LLC and Providence Resources LLC. All material intercompany accounts and transactions have been eliminated in the consolidation of the entities.
Cash and Cash Equivalents
The Company considers cash in operating and money market accounts to be cash and cash equivalents for the statement of cash flows.
Accounts Receivable
The Company considers accounts receivable to be fully collectible; accordingly no allowance for doubtful accounts is required. When amounts become uncollectible, they are charged to operations when that determination is made. Using this direct write-off method does not materially differ from the allowance method.
Property and Equipment
Drilling and service rigs and equipment are recorded at cost and are depreciated over their estimated useful lives of ten years using the straight-line method. Office furniture and equipment and automotive equipment are recorded at cost and depreciated over their estimated useful lives of five to ten years using the straight-line method.
FD-7
PROVIDENCE EXPLORATION, LLCNOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005
Property and Equipment (continued)
Upon sale or retirement of property and equipment the cost and related accumulated depreciation or depletion of the asset are removed from the Company’s accounts and gain or loss is recognized.
Expenditures for repair and maintenance are charged to expense as incurred.
Oil and Gas Leases Not Subject to Amortization
Oil and gas lease costs are recorded at cost and consist of 6,272.5 acres of land leases in North Eastern Texas in the Barnett Shale Formation. These leases are undeveloped at December 31, 2005, and accordingly no depletion is included in the accompanying consolidated financial statements. The Company paid cash of $3,136,273 for an undivided 90% working interest in the above mentioned oil leases from Harding Company, the operating company for the lease and 10% working interest holder.
The Company follows the full cost method of accounting for exploration and development of oil and gas properties whereby all costs in acquiring, exploring and developing properties are capitalized, including estimate of abandonment costs, net of estimated equipment salvage costs. No costs related to production, general corporate overhead, or similar activities have been capitalized. At December 31, 2005 the Company only had capitalized costs of unproved properties acquired during the year. Leasehold costs are depleted based on the units-of-production method based on estimated proved reserves. No proved reserves currently exist for the Company and therefore no depletion has been taken as of December 31. 2005.
In accordance with Statement of Financial Accounting Standards No. 144 “Accounting for the Impairment or Disposal of Long-Lived Assets”, the Company reviews its long-lived assets to be held and used, excluding proved oil and gas properties accounted for under the full cost method of accounting, whenever events or circumstances indicate that the carrying value of those assets may not be recoverable. An impairment loss is indicated if the sum of the expected future net cash flows is less than the carrying amount of the assets. In this circumstance, the Company recognizes an impairment loss for the amount by which the carrying amount of the asset exceeds the estimated fair value of the asset. The Company’s long-lived assets related to its proved oil and gas properties accounted for under the full cost method of accounting are prescribed by the Securities and Exchange Commission (Regulation S-X, Rule 4-10, “Financial Accounting and Reporting for Oil and Gas Producing Activities Pursuant to the Federal Securities Laws and the Energy Policy and Conservation Act of 1975”).
Fair Market Value of Financial Instruments
The estimated fair value of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses and other liabilities approximate their carrying amounts in the financial statements. The Company’s financial instruments include notes payable. The carrying value of notes payable approximates market value because the borrowing rate is similar to other financial instruments with similar terms.
FD-8
PROVIDENCE EXPLORATION, LLCNOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005
NOTE 1 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued):
Revenue Recognition
The Company generated revenues during 2005 from service fees generated from its drilling rigs. Revenues are recorded upon the completion of the services, with the existence of an agreement and where collectability is reasonably assured. Oil and natural gas production revenue will be recognized at the time and point of sale after the product has been extracted from the ground.
Intangible Assets
Loan origination fees are being amortized on a straight line basis over the 36 month term of the loans.
Income Taxes
The Company is organized as a Limited Liability Company (LLC) and is taxed for federal income tax purposes as a partnership. Accordingly, no federal income tax liability or expense is included in the accompanying financial statements. Income from the Company is taxed to the partners on their respective returns.
NOTE 2 — USE OF ESTIMATES IN PREPARATION OF FINANCIAL STATEMENTS:
The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
NOTE 3 — NOTES RECEIVABLE:
At December 31, 2005, the Company has a $5,000 note receivable from Nomatterware NEV. The note receivable is unsecured and noninterest bearing. The note receivable was repaid in January 2006.
The Company made advances to a member during the period ended December 31, 2005 totaling $87,418. Effective December 31, 2005, the company converted the advances to a note receivable. The note receivable is unsecured and bears interest at 4.25%. The note receivable and unpaid interest is due December 31, 2008.
FD-9
PROVIDENCE EXPLORATION, LLCNOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005
NOTE 4 - LONG-TERM DEBT:
Note Payable - FAGEB AG, secured by drilling equipment, payable in
quarterly installments of $25,119 through July 31, 2008, including
interest at 12%.
$232,443
Note Payable - Global Convertible Megatrend LTD., secured by
drilling equipment, payable in quarterly installments of $50,238
through July 31, 2008, including interest at 12%.
464,889
Note Payable - FAGEB AG, secured by drilling equipment, payable in
quarterly installments of $37,722 through September 25, 2008,
including interest at 12%. 349,204
Total 1,046,536
Less current portion 341,919
Long-term notes payable $ 704,617
Aggregate maturities of long term notes payable at December 31, 2005, are as follows:
Year Ended
December 31 Amount
2007 $384,791
2008 319,826
Total $704,617
NOTE 5 — MEMBERS’ CAPITAL:
Upon formation, the Members contributed $535,000 of capital to the Company.
NOTE 6 — MAJOR CUSTOMERS:
The Company had four major customers for the period ended December 31, 2005, which comprised 37%, 22%, 19% and 19% of total sales.
FD-10
PROVIDENCE EXPLORATION, LLCNOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005
NOTE 7 — SHORT TERM NOTES PAYABLE:
Notes payable - Swan Lake, unsecured, due December 31, 2006, plus
interest at 12 %, convertible into equity at $1.00 per share.
$350,000
Notes payable - Carerra, unsecured, due January 31, 2006, plus
interest at 12 %, convertible into equity at $1.00 per share.
150,000
Notes payable - Carrera, unsecured, due February 28, 2006, plus
interest at 12 %. 125,000
Notes payable - Healthbridge, Inc., secured by oil and
gas leases, due December 1, 2006, plus interest at 7 %.
(Note 8). 3,075,000
Total $3,700,000
NOTE 8 — PROPOSED TRANSACTION:
At December 31, 2005, the Company has a proposed transaction pending with Healthbridge, Inc., (a publicly owned Texas Corporation headquartered in Vancouver, B.C., Canada), whereby Healthbridge Inc. would acquire 100 percent ownership interest in the Company (including subsidiaries) in exchange for 16,500,000 shares of Healthbridge, Inc. common stock.
At December 31, 2005, Healthbridge Inc. has advanced the Company $3,075,000 to fund the purchase of the Company’s oil and gas leases.
NOTE 9 — AGREEMENT:
In October 2005, the Company signed a joint exploration agreement with Harding Company. Under the terms of the agreement, the Company and Harding Company intend to explore, develop and produce oil and gas from Marble Falls and Barnett Shale formations in targeted areas of the Ft. Worth basin. Harding Company is appointed as operator.
Providence is required pursuant to the agreement to fund 100% of all costs of the management and operation for a minimum of 3 wells. Providence will carry Harding for its 10% working interest in all wells drilled and completed through the pipeline connection phase, in the project.
FD-11
PROVIDENCE EXPLORATION, LLCNOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005
NOTE 10 — COMMITMENTS AND CONTINGENCIES:
The Company leases office and warehouse space under an operating lease which expires October 1, 2007. The Company leases a vehicle under an operating lease which expires in October 2007.
Minimum future rental payments under noncancelable operating leases having remaining terms in excess of one year at December 31, 2005, are as follows:
Year Amount
2006 $19,869
2007 12,502
Total $32,371
Rent expense was $7,796 for the period ended December 31, 2005. Automobile lease expense is included in automobile expense in the accompanying statement of income and members’ equity.
NOTE 11 – GOING CONCERN
As of December 31, 2005, the Company’s revenue generating activities have not generated sufficient funds for profitable operations, and the Company has a significant working capital deficit. These factors raise substantial doubt about the Company’s ability to continue as a going concern. Managements plan is to effect a merger with Healthbridge, Inc. subsequent to December 31, 2005, thus converting and eliminating the short-term and long term loans to equity in Healthbridge. Healthbridge will also assist in raising the needed funds for continued development of the oil & gas leases. If the merger does not occur, the company may not have sufficient funds to continue the development of its leases. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
NOTE 12 - SUPPLEMENTARY OIL AND GAS INFORMATION - FAS 69 (unaudited)The following unaudited disclosures on standardized measures of discounted cash flows and changes therein relating to proved oil and gas reserves are determined in accordance with United States Statements of Financial Accounting Standards No. 69 “Disclosures About Oil and Gas Producing Activities”.
FD-12
PROVIDENCE EXPLORATION, LLCNOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005
NOTE 12 — SUPPLEMENTARY OIL AND GAS INFORMATION – FAS 69 (unaudited) (Continued)
Standardized Measure of Discounted Future Net Cash Flows and Changes Therein
In calculating the standardized measure of discounted future net cash flows, year-end constant prices and cost assumptions were applied to the Company’s annual future production from proved reserves to determine cash inflows. Future production and development costs are based on constant price assumptions and assume the continuation of existing economic, operating and regulatory conditions. Future income taxes are calculated by applying statutory income tax rates to future pre-tax cash flows after provision for the tax cost of oil and natural gas properties based upon existing laws and regulations. The discount was computed by application of a 10 percent discount factor to the future net cash flows. The calculation of the standardized measure of discounted future net cash flows is based upon discounted future net cash flows prepared by the Company’s independent qualified reserve evaluators in relation to the reserves they respectively evaluated, and adjusted by the Company to account for management’s estimate obligations and future income taxes. The Company cautions that the discounted future net cash flows relating to proved oil and gas reserves are an indication of neither the fair market value of the Company’s oil and gas properties, nor of the future net cash flows expected to be generated from such properties. The discounted future net cash flows do not include the fair market value of exploratory properties and probable or possible oil and gas reserves, nor is consideration given to the effect of anticipated future changes in crude oil and natural gas prices, development, asset retirement and production costs, and possible changes to tax and royalty regulations. The prescribed discount rate of 10 percent may not appropriately reflect future interest rates. The Company’s projections should not be interpreted as being equivalent to fair market value.
Net Proved Reserves (1, 2)
Natural Gas Crude Oil and Natural Gas Liquids
(millions of cubic (thousands of barrels)
feet)
2005
Beginning of year - -
Purchase of reserves in place - -
Production - -
Adjustment for uneconomic wells - -
End of year - -
Developed - -
Undeveloped - -
Total - -
(2) Definitions:
a. | “Net” reserves are the remaining reserves of the Company, after deduction of estimated royalties and including royalty interests. |
FD-13
PROVIDENCE EXPLORATION, LLCNOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005
NOTE 12 — SUPPLEMENTARY OIL AND GAS INFORMATION – FAS 69 (unaudited) (Continued)
b. | “Proved oil and gas reserves.” Proved oil and gas reserves are the estimated quantities of crude oil, natural gas, and natural gas liquids which geological and engineering data demonstrate with reasonable certainty to be recoverable in future years from known reservoirs under existing economic and operating conditions, i.e., prices and costs as of the date the estimate is made. Prices include consideration of changes in existing prices provided only by contractual arrangements, but not on escalations based upon future conditions. |
i. | | Reservoirs are considered proved if economic product ability is supported by either actual production or conclusive formation test. The area of a reservoir considered proved includes that portion delineated by drilling and defined by gas-oil and /or oil-water contacts, if any; and the immediately adjoining portions not yet drilled, but which can be reasonably judged as economically productive on the basis of available geological and engineering data. In the absence of information on fluid contacts, the lowest known structural occurrence of hydrocarbons controls the lower proved limit of the reservoir. |
ii. | | Reserves which can be produced economically through application of improved recovery techniques (such as fluid injection) are included in the “proved” classification when successful testing by a pilot project, or the operation of an installed program in the reservoir, provides support for the engineering analysis on which the project or program was based. |
iii. | | Estimates of proved reserves do not include the following: |
| Oil that may become available from known reservoirs but is classified separately as “indicated additional reserves”; |
| Crude oil, natural gas, and natural gas liquids, the recovery of which is subject to reasonable doubt because of uncertainty as to geology, reservoir characteristics, or economic factors; |
Crude oil, natural gas, and natural gas liquids, that may occur in undrilled prospects; and
| Crude oil, natural gas, and natural gas liquids, that may be recovered from oil shale, coal, gilsonite and other such sources. |
FD-14
PROVIDENCE EXPLORATION, LLCNOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005
NOTE 12 — SUPPLEMENTARY OIL AND GAS INFORMATION – FAS 69 (unaudited) (Continued)
c. | “Proved developed oil and gas reserves.” Proved developed oil and gas reserves are reserves that can be expected to be recovered through existing wells with existing equipment and operating methods. Additional oil and gas expected to be obtained through the application of fluid injection or other improved recovery techniques for supplementing the natural forces and mechanisms of primary recovery should be included as “proved developed reserves” only after testing by a pilot project or after the operation of an installed program has confirmed through production response that increased recovery will be achieved. |
d. | “Proved undeveloped reserves.” Proved undeveloped oil and gas reserves are reserves that are expected to be recovered from new wells on undrilled acreage, or from existing wells where a relatively major expenditure is required for recompletion. Reserves on undrilled acreage shall be limited to those drilling units offsetting productive unites that are reasonably certain of production when drilled. Proved reserves for other undrilled unites can be claimed only where it can be demonstrated with certainty that there is continuity of production from the existing productive formation. Under no circumstances should estimates, for proved undeveloped reserves be attributable to any acreage for which an application of fluid injection or other improved recovery technique is contemplated, unless such techniques have been proved effective by actual tests in the area and in the same reservoir. |
(2) | | The Company does not file any estimates of total net proved crude oil or natural gas reserves with any U.S. federal authority or agency other than the SEC. |
Standardized Measure of Discounted Future Net Cash Flows Related to Proved Oil and Gas Reserves
The company has no proved reserves and no oil and gas production and therefore has not presented the Standardized Measure of Discounted Future Net Cash Flows or operating results.
Capitalized Costs
United States Year ended December 31, 2005 Proved oil and gas properties $_________________
Unproved oil and gas properties 3,136,273 Total capital costs 3,136,273 Accumulated depletion (-) Net capitalized costs $ 3,136,273FD-15
PROVIDENCE EXPLORATION, LLCNOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005
NOTE 12 — SUPPLEMENTARY OIL AND GAS INFORMATION – FAS 69 (unaudited) (Continued)
Costs Incurred
United States
Year ended December 31, 2005
Acquisitions:
Proved reserves $ -
Unproved reserves 3,163,273
Total acquisitions 3,163,273
Exploration costs -
Development costs -
Asset retirement obligations -
Total costs incurred $ 3,163,273
FD-16
HEALTHBRIDGE AND SUBSIDIARIES
Pro Forma for the Quarter Ended March 31, 2006
INDEX
Page
Combined Pro Forma Balance Sheet..........................................................................FE-2
Combined Pro Forma Statement of Operations................................................................FE-4
Notes to the Combined Pro Forma Financial Statements......................................................FE-5
FE-1
HEALTHBRIDGE INC. AND SUBSIDIARIES
Combined Pro Forma Balance Sheet
March 31, 2006
ASSETS
Healthbridge Providence
Inc. Exploration Pro Forma
(Parent) LLC Adjustments Pro Forma
March 31, March 31, Increase Combined
2006 2006 (Decrease) (Unaudited)
------------------ ------------------ ------------------ --------------------
CURRENT ASSETS
Cash and cash equivalents $ 770,412 $ 11,259 $ 781,671
Accounts receivable, net - 82,322 82,322
Promissory note receivable (incl. interest) 4,283,046 - (d) (4,283,046) -
Prepaid expenses and deposits - 31,098 31,098
------------------ ------------------ --------------------
Total Current Assets 5,053,458 124,679 895,090
------------------ ------------------ --------------------
PROPERTY AND EQUIPMENT, Net - 1,815,856 1,815,856
------------------ ------------------ --------------------
OTHER ASSETS
Undeveloped reserves - 4,868,593 (b) 3,405,845 8,274,438
Loan origination fees, net of amortization of $5,035 - 64,861 64,861
Notes receivable-long term - 117,418 117,418
Deposits - 2,266 2,266
------------------ ------------------ --------------------
Total Other Assets - 5,053,138 8,458,983
------------------ ------------------ --------------------
TOTAL ASSETS 5,053,458 $ 6,993,673 (877,201) $11,169,929
================== ================== ================== ====================
FE-2
HEALTHBRIDGE INC. AND SUBSIDIARIES
Combined Pro Forma Balance Sheet (Continued)
March 31, 2006
LIABILITIES AND STOCKHOLDERS' EQUITY
Healthbridge Providence
Inc. Exploration Pro Forma
(Parent) LLC Adjustments Pro Forma
March 31, March 31, Increase Combined
2006 2006 (Decrease) (Unaudited)
------------------- ----------------- -------------------- --------------------
CURRENT LIABILITIES
Accounts payable and accrued liabilities $ 53,884 $ 757,341 $ 811,225
Accrued expenses 127,020 196,252 (d) (75,726) 247,546
Related party payables 27,403 - 27,403
Note payable - 4,832,320 (d) (4,207,320) -
(e) (625,000)
Current portion of L-T notes payable - 352,178 352,178
------------------- ----------------- --------------------
Total Current Liabilities 208,307 6,138,091 1,438,352
------------------- --- ----------------- --------------------
LONG-TERM LIABILITIES
Convertible debentures 3,645,000 - 3,645,000
L-T notes payable - 1,462,676 1,462,676
------------------- ----------------- --------------------
Total Long-Term Liabilities 3,645,000 1,462,676 5,107,676
------------------- ----------------- --------------------
Total Liabilities 3,853,307 7,600,767 6,546,028
------------------- --- ----------------- --------------------
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock; $0.0001 par value, 25,000,000 shares
authorized,
no shares issued and outstanding - - -
Common stock; $0.0001 par value, 50,000,000 shares authorized,
32,980,906 shares issued and outstanding 1,648 - (a) 1,650 3,298
Additional paid-in capital 10,425,371 - (a) 3,422,100 13,847,471
Accumulated other comprehensive income 18,219 - 18,219
Accumulated deficit (9,245,087) - (9,245,087)
Member's equity - (607,095) (c) 607,095 -
------------------- ----------------- --------------------
Total Stockholders' Equity (Deficit) 1,200,151 (607,095) 4,623,901
------------------- --- ----------------- --------------------
TOTAL LIABILITIES AND STOCKHOLDERS'EQUITY (DEFICIT) $ 5,053,458 $ 6,993,672 (877,201) $11,169,929
=================== ================= ==================== ====================
FE-3
HEALTHBRIDGE INC. AND SUBSIDIARIES
Combined Pro Forma Statements of Operations
Healthbridge
Inc. Providence
Exploration
(Parent) LLC
For the For the Pro Forma
Year Ended Year Ended Adjustments
March 31, March 31, Increase Pro Forma
2006 2006 (Decrease) Combined
---------------- --------------- -------------- ----------------
(Unaudited)
REVENUES $ - $ 348,142 $ 348,142
COST OF SALES - 430,981 - 430,981
---------------- --------------- -------------- ----------------
GROSS MARGIN - (82,839) - (82,839)
---------------- --------------- -------------- ----------------
OPERATING EXPENSES
General and administrative 98,806 182,532 281,338
Total Operating Expenses 98,806 182,532 - 281,338
---------------- --------------- -------------- ----------------
LOSS FROM OPERATIONS (98,806) (265,371) - (364,177)
---------------- --------------- -------------- ----------------
OTHER INCOME (EXPENSE)
Interest income 72,153 36 72,189
Interest expense (65,333) (97,996) (163,329)
Total Other Income (Expense) 6,820 (97,960) - (91,140)
---------------- --------------- -------------- ----------------
LOSS BEFORE PROVISION FOR INCOME TAXES (91,986) (363,331) (455,317)
Provision for income taxes - - -
NET LOSS (91,986) (363,331) (455,317)
OTHER COMPREHENSIVE INCOME
Foreign currency translation adjustment 3,849 - 3,849
NET COMPREHENSIVE INCOME (LOSS) $ (88,137) $ (363,331) $ (451,468)
================ =============== ============== ================
FE-4
Healthbridge, Inc and Subsidiaries
Notes to Pro Forma Consolidated Financial Statements
March 31, 2006
NOTE 1 — Summary of Transaction
.........On November 18, 2005, the Company signed a letter of intent and publicly announced the acquisition of Providence Exploration LLC. Pursuant to the agreement, Healthbridge will issue 16, 500,000 shares of common stock for all outstanding shares of Providence. The acquisition was valued at $.2075 per share, ($3,423,750). The shares of Healthbridge would be distributed to the shareholders and note holders of Providence. The remaining debt in Providence would be debt owed to Healthbridge and will be eliminated in consolidation. This transaction made Providence become a wholly owned subsidiary of the Company, and is accounted for on the purchase method of accounting using generally accepted accounting principles. All asset and assumed liabilities of Providence would be recorded and the remaining acquisition value was recorded as undeveloped oil reserves.
NOTE 2 — Management Assumptions
..........The pro forma consolidated balance sheet and statements of operations assumes that the entities were together as of March 31, 2006. .........The pro forma consolidated balance sheet assumes: (a) the issuance of the 16,500,000 shares of stock at $.2075, (b) the recognition of undeveloped reserves, (c) the elimination of the members' capital of Providence, (d) the elimination of the intercompany note receivable and note payable and (e) the conversion of $625,000 of notes payable. .........There are no proforma adjustments for the statement of operations.FE-5
HEALTHBRIDGE AND SUBSIDIARIES
Pro Forma for the year ended December 31, 2005
INDEX
Page
Combined Pro Forma Balance Sheet..........................................................................FF-2
Combined Pro Forma Statement of Operations................................................................FF-4
Notes to the Combined Pro Forma Financial Statements......................................................FF-5
FF-1
HEALTHBRIDGE INC. AND SUBSIDIARIES
Combined Pro Forma Balance Sheet
December 31, 2005
ASSETS
Healthbridge Providence
Inc. Exploration Pro Forma
(Parent) LLC Adjustments Pro Forma
December December
31, 31, Increase Combined
2005 2005 (Decrease) (Unaudited)
------------- ------------- --------------- ------------
CURRENT ASSETS
Cash and cash equivalents 2,035,438 22,060 2,057,498
Accounts receivable, net - 72,833 72,833
)
Promissory note receivable (incl. interest) 3,091,901 5,000 (d (3,091,901) 5,000
Prepaid expenses and deposits - 34,449 34,449
------------- ------------- ------------
Total Current Assets 5,127,339 134,342 2,169,780
------------- ------------- ------------
PROPERTY AND EQUIPMENT, Net 1,019 1,211,839 1,212,858
------------- ------------- ------------
OTHER ASSETS
Undeveloped reserves - 3,136,273 (b) 3,042,514 6,178,787
Loan origination fees, net of amortization of
$5,035 - 71,215 71,215
Notes receivable-long term - 87,418 87,418
Deposits - 2,266 2,266
------------- ------------- ------------
Total Other Assets - 3,297,172 6,339,686
------------- ------------- ------------
$
TOTAL ASSETS 5,128,358 4,643,353 (49,387) 9,722,324
============= ============= =============== ============
FF-2
HEALTHBRIDGE INC. AND SUBSIDIARIES
Combined Pro Forma Balance Sheet (Continued)
December 31, 2005
LIABILITIES AND STOCKHOLDERS' EQUITY
Healthbridge Providence
Inc. Exploration Pro Forma
(Parent) LLC Adjustments Pro Forma
December December
31, 31, Increase Combined
2005 2005 (Decrease) (Unaudited)
------------- ------------- ---------------- ------------
CURRENT LIABILITIES
Accounts payable and accrued liabilities $ 119,867 $ 26,615 $ 146,482
Accrued expenses 61,703 113,966 (d) (16,901.00) 158,768
Related party payables 13,500 - 13,500
Note payable - 3,700,000 (d) (3,075,000) -
(e) (625,000)
Current portion of L-T notes payable - 341,919 341,919
------------- ------------- ------------
Total Current Liabilities 195,070 4,182,500 660,669
------------- ------------- ------------
LONG-TERM LIABILITIES
Convertible debentures 3,645,000 - 3,645,000
L-T notes payable - 704,617.00 704,617
------------- ------------- ------------
Total Long-Term Liabilities 3,645,000 704,617 4,349,617
------------- ------------- ------------
Total Liabilities 3,840,070 4,887,117 5,010,286
------------- ------------- ------------
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock; $0.0001 par value, 25,000,000
shares authorized, no shares issued and
outstanding
Common stock; $0.0001 par value, 50,000,000
shares authorized,
32,980,906 shares issued and outstanding 1,648 - (a) 1,650 3,298
Additional paid-in capital 10,425,371 - (a) 3,422,100 13,847,471
Accumulated other comprehensive income 14,370 - 14,370
Accumulated deficit (9,153,101) - (9,153,101)
Member's equity - (243,764) (c) 243,764 -
------------- ------------- ------------
Total Stockholders' Equity (Deficit) 1,288,288 (243,764) 4,712,038
------------- ------------- ------------
TOTAL LIABILITIES AND STOCK-
HOLDERS' EQUITY (DEFICIT) $5,128,358 $4,643,353 (49,387) $ 9,722,324
============= ============= ================ ============
FF-3
HEALTHBRIDGE INC. AND SUBSIDIARIES
Combined Pro Forma Statements of Operations
Healthbridge Providence
Inc. Exploration
(Parent) LLC
For the For the Pro Forma
Year Ended Year Ended Adjustments Pro Forma
December 31, December 31, Increase Combined
2005 2005 (Decrease) (Unaudited)
------------- ------------- --------------- ---------------
REVENUES $ - $ 369,515 $ 369,515
COST OF SALES - 694,382 694,382
------------- ------------- ---------------
GROSS MARGIN - (324,867) (324,867)
------------- ------------- ---------------
OPERATING EXPENSES
General and administrative 468,677 278,131 746,808
Total Operating Expenses 468,677 278,131 746,808
------------- ------------- ---------------
LOSS FROM OPERATIONS (468,677) (602,998) (1,071,675)
OTHER INCOME (EXPENSE)
Interest income 23,585 38 23,623
Interest expense (200,517) (86,073) (286,590)
Note receivable write off - (89,731) (89,731)
------------- ------------- ---------------
Total Other Income (Expense) (176,932) (175,766) (352,698)
------------- ------------- ---------------
LOSS BEFORE PROVISION FOR INCOME TAXES (645,609) (778,764) (1,424,373)
AND DISCONTINUED OPERATIONS
Provision for income taxes - - -
LOSS BEFORE DISCONTINUED OPERATIONS (645,609) (778,764) (1,424,373)
Gain (loss) from discontinued operations, net
of tax (299,248) - (299,248)
NET LOSS (944,857) (778,764) (1,723,621)
OTHER COMPREHENSIVE INCOME
Foreign currency translation adjustment 9,057 - 9,057
NET COMPREHENSIVE INCOME (LOSS) (935,800) $ (778,764) $(1,714,564)
============= ============= =============== ===============
FF-4
Healthbridge, Inc and Subsidiaries
Notes to Pro Forma Consolidated Financial Statements
December 31, 2005
NOTE 1 — Summary of Transaction
.........On November 18, 2005, the Company signed a letter of intent and publicly announced the acquisition of Providence Exploration LLC. Pursuant to the agreement, Healthbridge will issue 16, 500,000 shares of common stock for all outstanding shares of Providence. The acquisition was valued at $.2075 per share, ($3,423,750). The shares of Healthbridge would be distributed to the shareholders and Note holders of Providence. The remaining debt in Providence would be debt owed to Healthbridge and will be eliminated in consolidation. This transaction made Providence become a wholly owned subsidiary of the Company, and is accounted for on the purchase method of accounting using generally accepted accounting principles. All asset and assumed liabilities of Providence would be recorded and the remaining acquisition value was recorded as undeveloped oil reserves.
NOTE 2 — Management Assumptions
..........The pro forma consolidated balance sheet and statements of operations assumes that the entities were together as of December 31, 2005. .........The pro forma consolidated balance sheet assumes: (a) the issuance of the 16,500,000 shares of stock at $.2075, (b) the recognition of undeveloped reserves, (c) the elimination of the members' capital of Providence, (d) the elimination of the intercompany note receivable and note payable, and (e) the conversion of $625,000 of Notes Payable. .........There are no proforma adjustments for the statement of operations.FF-5
Securities Exchange Agreement
BETWEEN
Healthbridge, Inc.
AND
Providence Exploration, LLC
AND
Unit Holders of Providence Exploration, LLC
DATED
April 10, 2006
36
SECURITIES EXCHANGE AGREEMENT
THIS SECURITIES EXCHANGE AGREEMENT (“Agreement”), is entered into as of April 10, 2006, by and between Healthbridge, Inc., a Texas corporation (“Company”) and Providence Exploration, LLC, a Texas limited liability company, and its subsidiaries (“Providence”), and Abram and Shirley Janz, the sole members of Providence (“Sellers”),
WITNESSETH:
WHEREAS, the Sellers own one million two hundred fifty thousand (1,250,000) membership units in Providence, which units constitute 100% of the outstanding ownership or right to ownership of Providence (the “Providence Units”);
WHEREAS, Providence has two wholly owned subsidiaries, specifically (i) PDX Drilling, LLC, an energy exploration services company, and (ii) Providence Resources, LLC;
WHEREAS, Providence has entered into a Joint Exploration Agreement with Harding Company, dated October 1, 2005, as amended, to purchase, explore and develop certain oil, gas and mineral interests underlying approximately 6,272 acres in Comanche and Hamilton Counties, Texas;
WHEREAS, Providence has entered into an Agreement of Purchase and Sale with Global Mineral Solutions, LP, dated March 31, 2006, to purchase, explore and develop certain oil, gas and mineral interests underlying approximately 12,832 acres in Val Verde County, Texas;
WHEREAS, the Company has entered into a commitment to loan up to five million dollars ($5,000,000) to Providence pursuant to a Secured Revolving Replacement Promissory Note, dated December 1, 2005, for the purpose of funding Providence’s purchase of said oil, gas and mineral interests and to fund Providence’s ongoing, exploration and development obligations under the Joint Exploration Agreement and the Agreement of Purchase and Sale; and
WHEREAS, contemporaneously with its execution of this Agreement the Company is entering into that certain Note Exchange Agreement (the “Note Exchange Agreement”) with certain individuals and entities (collectively, the “Holders”) to whom the Providence is indebted as evidenced by certain Convertible Promissory Notes (the “Notes”), pursuant to which Note Exchange Agreement the Holders have agreed to exchange the Notes for certain shares of the $0.0001 par value common stock of the Company (“Company Shares”);
WHEREAS, the Company desires to acquire from the Sellers, and the Sellers desire to convey to the Company, all of the Providence Units in exchange for an aggregate of four million two hundred eighty-six thousand three hundred thirty (4,286,330) Company Shares distributed to the Sellers.
WHEREAS, the Holders have made it a condition to closing of the transactions contemplated in the Note Exchange Agreement that the transactions contemplated in this Agreement be consummated; and Sellers have made it a condition to closing of the transactions contemplated in this Agreement that the transactions contemplated in the Note Exchange Agreement be consummated.
NOW, THEREFORE, in consideration of the premises and of the mutual representations, warranties and agreements set forth herein, the parties hereto agree as follows:
37
ARTICLE I
DEFINITIONS AND INTERPRETATION
1.1 Defined Terms. Unless otherwise specifically defined in this Agreement or the context otherwise requires, capitalized terms used in this Agreement shall have the following meanings: | 1.1.1 “Affiliate” or “Affiliated” means, in relation to any party, any company or other commercial entity or person which directly or indirectly controls, is controlled by or is under common control with such party or any of such party’s directors, managers, supervisors or management personnel. |
| 1.1.2 “Agreement” means this agreement, the recitals hereto and all Exhibits and Schedules attached to this Agreement, in each case, as they may be amended or supplemented from time to time, and the expressions “hereof”, “herein”, “hereto”, “hereunder”, “hereby”, and similar expressions, when used in this Agreement, refer to this Agreement as a whole and not to any particular provision of this Agreement; and unless otherwise indicated, references to sections and subsections are to sections and subsections in this Agreement. |
| | | | 1.1.3 | | “Applicable Law” means any domestic or foreign statute, law, ordinance, regulation, by-law or order that applies to the Company, Providence, or the Sellers. |
| | | | 1.1.4 | | “Assets” means all of the properties, rights and assets of Providence including, without limitation, Inventory, cash and cash equivalents, all investments, accounts receivable, drilling and service rigs, Goodwill, Lands, Fixed Plant and Equipment, Personal Property and Material Contracts. |
| 1.1.5 “Business” means the business of providing energy exploration services and the business of exploring, developing and producing oil and gas. |
| 1.1.6 “Business Day” means any day other than a Saturday, a Sunday or a day on which chartered banks in the United States of America are authorized or obligated by law to close. |
1.1.7 "Closing Date" has the meaning set forth in subsection 2.7. | 1.1.8 “Employees” means all persons engaged in the Business including employees, employees on leave, contract employees and owner-operators, if any. |
| 1.1.9 “Encumbrance” means any encumbrance of any kind whatever and includes, without limitation, any adverse claim, security interest, mortgage, lien, hypothecation, pledge, assignment, charge, trust or deemed trust (whether contractual, statutory or otherwise arising), or any other right, option or claim of others affecting the Assets, and any covenant or other agreement, restriction or limitation on the transfer of the Assets. |
| 1.1.10 “Environmental Laws” includes all applicable laws, statutes, regulations, by-laws, rules and Orders of any Governmental Authority where Providence has carried on business and the common law, relating, in whole or in part, to the environment, and includes those laws relating to the storage, generation, use, handling, manufacture, processing, transportation, import, export, treatment, release or disposal of any Hazardous Substance. |
| 1.1.11 “Environmental Permits” includes all certificates, approvals, consents, authorizations, registrations, and licenses issued, granted, conferred, created or required by any Governmental Authority pursuant to any Environmental Laws. |
38
| 1.1.12 “Facilities” means: (a) the offices of Providence located at 100 Crescent Court, 7th Floor, Dallas, Texas, 75201; and (b) PDX Drilling, LLC’s leased property in Graham, Texas. |
| 1.1.13 “Financial Statements” means the audited financial statements of Providence for the period ending December 31, 2005 and the interim financial statements of Providence for the period ended March 31, 2006, consisting of a balance sheet, income statements, statements of operations and notes, copies of which are attached hereto as Exhibit A. |
1.1.14 “Fixed Plant and Equipment” means all plant, machinery and equipment situated on the Lands, if any.
| 1.1.15 “Governmental Authority” includes any domestic or foreign government whether state, federal, provincial, or municipal and any governmental agency, governmental authority, governmental tribunal or governmental commission of any kind whatsoever. |
1.1.16 "Goodwill" means: 1.1.16.1 all customer lists, contracts, files, records and outstanding quotations; | 1.1.16.2 all trade marks (registered or not), trade names, designs, URL and domain names, logos, industrial design applications and copyrights (registered or not) used in the Business; |
1.1.16.3 all trade secrets and confidential information of Providence in relation to the Business;
1.1.16.4 all know-how of the Business including:
| 1.1.16.4.1 all information of a scientific or technical nature whether in oral, written, graphic, machine readable, electronic or physical form; and |
| 1.1.16.4.2 all patterns, plans, designs, research data, research plans, trade secrets and other proprietary know-how, processes, formulas, drawings, technology, blue prints, flow sheets, equipment and parts lists, instructions, manuals, records and procedures. |
| 1.1.17 “Hazardous Substance” means any hazardous waste, hazardous substance, hazardous material, toxic substance, dangerous substance or dangerous good or contaminant as defined or identified in any Environmental Law. |
1.1.18 “Inventory” means all inventories of products relating to the Business, all supplies, and equipment relating thereto.
| 1.1.19 “Lands” means the lands leased by Providence in relation to the Business including, without limitation, the lands on which the Facilities are located, the leased mineral interests underlying approximately 6,272 acres in Comanche and Hamilton Counties, Texas, and the leased mineral interests underlying approximately 12,832 acres in Val Verde County, Texas. |
| 1.1.20 “Loss” means any and all loss, liability, damage, cost or expense actually suffered or incurred by a party resulting from the subject matter of any claim, including the costs and expenses of any action, suit, proceeding, demand, assessment, judgment, settlement or compromise relating thereto (including legal fees on a solicitor’s and his own client basis), net of any tax savings arising as a result of expensing the same, less the amount of any judgment awarded as a result of any counterclaim or set-off relating to that claim. |
39
1.1.21 “Material Contracts” means those agreements listed in Exhibit B hereto.
| 1.1.22 “Order” means any order, judgment, injunction, decree, award or writ of any court, tribunal, arbitrator, Governmental Authority, or other person who is authorized to make legally binding determinations. |
| 1.1.23 “Permits” means all permits, licenses, authorizations, agreements or understandings relating to the Business and issued by any Governmental Authority, or to which any Governmental Authority is a party, including, without limitation, the Environmental Permits. |
1.1.24 “Permitted Encumbrances” means those encumbrances listed in Exhibit C hereto.
| 1.1.25 “Personal Property” means all of the equipment, vehicles, machinery, furniture, chattels and other tangible personal property used in the Business as at the Closing Date and any and all operating manuals, warranty information or other documentation relating thereto. |
| 1.1.26 “Pollution” means any type of environmental damage or contamination which contravenes any Environmental Law, including, without limiting the generality of the foregoing, damage to or contamination by any substance, waste, or goods including, without limiting the generality of the foregoing, any Hazardous Substance. |
| 1.1.27 “Promissory Note” means the Secured Revolving Replacement Promissory Note, dated December 1, 2005, executed by Providence in favor of the Company that commits the Company to loan an amount of up to five million dollars ($5,000,000) to Providence on or before the Closing Date. |
| 1.1.28 “Providence” means Providence Exploration, LLC, and it’s wholly owned subsidiaries: PDX Drilling, LLC, an energy exploration services company and Providence Resources, LLC, an oil and gas exploration company, both of which are Texas limited liability companies. |
1.1.29 “Sellers” means those individuals or entities detailed in Exhibit D hereto.
1.1.30 "Taxes" means all taxes and similar governmental charges, including: | 1.1.30.1 state, federal, provincial, municipal and local, foreign or other income, franchise, capital, real property, personal property, withholding, payroll, employer health, transfer, sales, use, excise, goods and services, consumption, countervail and value added taxes, all other taxes of any kind relating to Providence, or the Business and imposed by any Governmental Authority, whether disputed or not; and |
| 1.1.30.2 assessments, charges, duties, fees, imposts, levies or other governmental charges and interest, penalties or additions associated therewith. |
| 1.1.31 “Tax Returns” means all reports, returns and other documents filed or required to be filed by Providence in relation to the Business in respect of Taxes or in respect of or pursuant to any domestic or foreign federal, provincial, state, municipal, territorial or other taxing statute. |
| | | | 1.2 | | Gender and Number. The terms defined in the singular shall have a comparable meaning when used in the plural and vice versa, and words importing gender include all genders. |
1.3 Currency. Unless specified, all references to currency in this Agreement shall mean United States dollars.40
1.4 Exhibits. The following Exhibits are attached hereto and form part of this Agreement:
Exhibit Description
------- -----------
A Financial Statements
B Material Contracts
C Permitted Encumbrances
D Sellers
1.5 Schedules. The following Schedules are attached hereto and form part of this Agreement:
Schedule Description
-------- -----------
3.1.15 Contracts
3.2.15 Company Contracts
1.6 Section Headings. The section and subsection headings contained in this Agreement are for reference purposes only and shall not in any way affect the meaning or interpretation of this Agreement.ARTICLE II
EXCHANGE OF SHARES FOR UNITS
| | | | 2.1 | | Exchange. Upon and subject to the terms of this Agreement, the Company hereby agrees to issue and deliver the Company Shares, which consist of four million two hundred eighty-six thousand three hundred thirty (4,286,330) shares of common stock, to the Sellers in the proportions set out on Exhibit D, and the Sellers hereby agree to exchange, assign, transfer and set over the Providence Units, which consist of one million two hundred fifty thousand (1,250,000) membership units issued by Providence, to the Company on the Closing Date, there being no outstanding preferred units, warrants or options to purchase units of Providence. |
| | | | 2.2 | | Fractional Shares. The Company shall not issue fractional Company Shares in exchange for the Providence Units, rather the Company will round fractional shares, if any, up to the next whole Company Share. |
2.3 Share Valuation Price. The valuation of the Providence Units shall be deemed equivalent to the valuation of the Company Shares. 2.4 Tax Free. The exchange of Providence Units for Company Shares will be deemed by the parties to be a tax free exchange. | | | | 2.5 | | Resale Restrictions. The Company Shares issued to Sellers shall be subject to resale restrictions imposed pursuant to the Securities Act of 1933 as amended and thus restricted for a period of at least twelve (12) months from the date of issuance. |
| | | | 2.6 | | Company Loans. The Company has committed to Providence, prior to the Closing Date, to loan Providence up to five million dollars ($5,000,000) pursuant to a Secured Revolving Replacement Promissory Note, dated December 1, 2005, as an inducement for Providence to enter into this Agreement, the receipt of approximately four million two hundred seven thousand three hundred five dollars ($4,207,305) of such monies being hereby acknowledged by Providence. |
2.7 Closing Date. The Closing Date of the transaction contemplated hereby shall take place on May 26, 2006, at the offices of Healthbridge, at 11 a.m. Pacific Daylight Time.41
ARTICLE III
REPRESENTATIONS AND WARRANTIES
| | | | 3.1 | | Sellers and Providence. The Sellers and Providence make the representations and warranties set out hereto to the Company, recognizing that the Company is relying on such representations and warranties in entering into the transactions contemplated by this Agreement. All due diligence searches, investigations or inspections by the Company, up to the Closing Date, are without prejudice to the Company’s right to rely upon the representations and warranties of the Sellers and Providence in entering into the transactions contemplated by this Agreement. The Sellers and Providence, jointly and severally, make these representations and warranties set out hereto to the Company: |
| 3.1.1 Formation and Qualification. Providence is duly formed limited liability company, organized and validly subsisting under the laws of the State of Texas. Providence has all requisite company power and authority to own, lease and operate its respective properties. Providence is duly registered, licensed or qualified to carry on the Business in the jurisdictions in which the nature of the Business as now being conducted by it or the property owned or leased by it makes such registration, licensing or qualification necessary. |
| 3.1.2 Authority, Filings, Consents and Approvals. Providence has all requisite company power and authority to enter into this Agreement and to perform the transactions contemplated by this Agreement. This Agreement has been duly authorized, executed and delivered by Providence and Sellers, and constitutes a legal, valid and binding obligation of Providence, enforceable in accordance with its terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability relating to or affecting creditors’ rights and to general equity principles. No other proceedings on the part of Providence or Sellers are necessary to authorize the entering into of this Agreement and the consummation of the transactions contemplated hereby. The execution, delivery and performance of this Agreement and the agreements contemplated herein will not require the Sellers, or Providence, to obtain any consent, waiver, authorization or approval of, or make any prior filing with or give notice to, any person, except for such consents, waivers, authorizations or approvals which the failure to obtain or provide same would not be reasonably likely to have a material adverse effect on the Business. |
| 3.1.3 Capitalization of Providence. The Providence Units are the only issued and outstanding membership units of Providence. The Providence Units are duly authorized, validly issued, fully paid and non-assessable and are owned of record and beneficially by the Sellers. |
| 3.1.4 The Providence Units. The Sellers have good and valid title to the Providence Units, free and clear of all Encumbrances. There are no outstanding options, warrants or rights to purchase or acquire, or securities convertible into or exchangeable for, any units or other securities in the capital of Providence, and there are no other contracts, commitments, agreements, understandings, arrangements or restrictions which require Providence to issue, sell or deliver any of its respective units or other securities. The Providence Units bear no restriction on transfer that would prohibit conveyance to the Company. |
42
| 3.1.5 Corporate Records. All transactions of Providence have been promptly and properly recorded or filed in or with its respective books and records, and the minute books contain complete and accurate records of the meetings and proceedings of unit holders and managers thereof. |
3.1.6 Providence Manager and Officers. The Manager and officers of Providence are as follows:
Sole Manager Officers
Abram Janz Abram Janz, President and Chief Executive Officer
Abram Janz, Chief Financial Officer
Abram Janz, Secretary
| 3.1.7 Liabilities. Except for the Permitted Encumbrances, Providence has no material liabilities of any kind whatsoever, contingent or non-contingent, other than those incurred in the ordinary course of business, including, without limitation, commercial real estate leases, utilities, telephone, and legal services. |
| 3.1.8 Liabilities at Closing. Except as may otherwise be set forth in Section 3.1.7 above, the value of all liabilities of Providence, including any exposure under any guarantees, as at the Closing Date, shall not be in excess of those normally incurred and paid in the ordinary course of business. |
| 3.1.9 Assets. Providence has good and marketable, legal and beneficial title to all of the property comprising the Assets, free and clear of all Encumbrances except for the Permitted Encumbrances. The Assets constitute all of the property, rights and other assets used by Providence, or which are necessary or desirable to conduct the Business as conducted prior to the date hereof. Without limiting the generality of the foregoing, none of the Personal Property or the Fixed Plant and Equipment is leased or otherwise used in the Business subject to any agreement with any third party. |
| 3.1.10 Corporate Records and Financial Statements. All material transactions relating to the Business have been promptly and properly recorded or filed in or with Providence’s books and records. The minute books of Providence contain complete and accurate records of the meetings and proceedings of unit holders and managers thereof. The Financial Statements of Providence for the period ending December 31, 2005 (audited) and March 31, 2006 (un-audited) (copies of which are attached hereto as Exhibit A), fairly and accurately present the financial condition of the Business as at such dates. |
| 3.1.11 Environmental Compliance. Except in compliance with Environmental Laws, to the knowledge of the Sellers, Providence has not caused or permitted, and Providence and the Sellers have no knowledge of, any material release or disposal by any person of any Hazardous Substance on or from any premises formerly or presently used in the Business. All Hazardous Substances generated, handled, stored, treated, processed, transported or disposed of in the course of the Business have been generated, handled, stored, treated, processed, transported or disposed of in all material respects, in compliance with applicable Environmental Laws and the Environmental Permits. |
| 3.1.12 Payment of Taxes. Providence has paid all Taxes due and payable in relation to the Business and has paid all assessments that Providence has received in respect of Taxes. |
43
| 3.1.13 Reassessments. No reassessments of Taxes have been issued against Providence in relation to the Business nor is Providence aware of any pending or threatened assessment or reassessment for Taxes. Providence has not executed or filed with any Governmental Authority any agreement extending the period for assessment, reassessment or collection of any Taxes. |
| 3.1.14 Withholdings. Providence has withheld from each payment made to any of the Employees of the Business or former Employees, officers and managers, and to all other persons, all amounts required by law and will continue to do so until the Closing Date and has remitted or will remit, such withheld amounts within the prescribed periods to the appropriate Governmental Authority. Providence has charged and collected and has remitted or will remit on a timely basis all Taxes as required by Applicable Law on any sale, supply or delivery whatsoever, made in relation to the Business. |
| 3.1.15 Contracts. Providence is not a party to, or bound by, any material contract, agreement or commitment of any kind in relation to the Business other than this Agreement and the Material Contracts. The Material Contracts are in full force and effect. There is not any pending or, to the knowledge of the Sellers, threatened cancellation, existing default, or event under any of the Material Contracts which, after notice or lapse of time, or both, would constitute a default under any of the Material Contracts. Except as set forth on Schedule 3.1.15, all of the Material Contracts are terminable on reasonable notice as required by Applicable Law if termination is not expressly provided for, or sixty (60) days notice or less if a time period prior to termination is provided. All quotations and price lists provided and outstanding to customers of the Business up to the Closing Date contain normal business terms for the Business and have been provided in the ordinary course of the Business. |
| 3.1.16 Employees. Complete and accurate particulars of the Employees pertaining to the date of hire of such Employees and their annual remuneration and the names of those on long term disability, workers’ compensation or leave of absence (if any) will be provided to the Company upon request. Providence does not have any written employment agreements relating to any of the Employees. |
| 3.1.17 Collective/Employment Agreements. None of the Employees is employed under a contract which cannot be terminated by Providence, with or without notice, including those Employees who are employed on indefinite hire requiring reasonable notice of termination by Applicable Law. Providence is not a party, either directly or by operation of law, to any collective bargaining agreement. No trade union, council of trade unions, employee bargaining agency or affiliated bargaining agent holds bargaining rights with respect to any of the Employees of the Business by way of certification, interim certification, voluntary recognition, or successor rights. There are no threatened or pending union organizing activities involving the Employees and there are no threatened labor disputes or work stoppages relating to, or connected with, the Business. |
| 3.1.18 Occupational Health and Safety. There are no outstanding inspection orders or charges or any other Orders made against Providence or the Business. Providence is in compliance with all occupational health and safety rules and regulations in all material respects in relation to the Business and there are no outstanding violations of such rules and regulations. |
44
| 3.1.19 Insurance. The Assets are insured by reputable insurers against liability, loss and damage in such amounts and against such risks as is prudent for the Business, and such insurance coverage will be continued in full force and effect up to and including the Closing Date. All insurance policies relating to the Business are in full force and effect and Providence is not in default with respect to any of the provisions contained in any such insurance policy. Providence is not aware of any events or occurrences that could reasonably form the basis for a claim under Providence’s policies of insurance. |
| 3.1.20 Permits. Providence is in possession of and is in compliance with all Permits required by any Governmental Authority which are necessary to conduct the Business. |
| 3.1.21 Absence of Legal Conflicts. The execution and delivery of this Agreement by the Sellers and Providence does not, and the performance of this Agreement by such parties of the transactions contemplated by this Agreement will not: |
| 3.1.21.1 conflict with or violate the constituent documents of Providence, or any resolution of the managers or unit holders of Providence; |
3.1.21.2 conflict with or violate any Applicable Law; or | 3.1.21.3 result in any breach of or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, or result in the creation of an Encumbrance on any of Assets pursuant to, any note, bond, mortgage, indenture, contract, agreement, lease, license, permit, franchise or other instrument or obligation to which the Sellers or Providence is a party in relation to the Business or by which the Business or the Assets is bound or affected, which, in any such case, would prohibit or delay such parties’ ability to perform their respective obligations under this Agreement. |
| 3.1.22 Litigation. There are no claims, actions, proceedings, suits, investigations or reviews pending or, to the knowledge of the Sellers, threatened against the Sellers or Providence or otherwise in relation to the Business or the Assets or the Providence Units, before or by any Governmental Authority or court. |
3.1.23 Conduct of Business - Changes. Since March 31, 2006: 3.1.23.1 Providence has conducted the Business in the ordinary course, using reasonable efforts to preserve the Business; 3.1.23.2 there has not been any material adverse change in the Assets, affairs or financial condition of the Business; 3.1.23.3 Providence has not: | 3.1.23.3.1 increased the compensation paid or payable to any of the Employees or increased the benefits to which the Employees are entitled or provided any new benefits for any such employees; or |
| 3.1.23.3.2 modified, amended or terminated any contract to which it is or was a party in relation to the Business, except in the ordinary course of business with a view to the best interests of the Business. |
45
| 3.1.24 Copies of Documents etc. True and complete copies of the documents and agreements listed in the Exhibits and Schedules hereto have been made available to the Company and its counsel for review. |
| 3.1.25 Investment Intent. The Sellers are acquiring the Company Shares for investment purposes only and not with a view of immediate resale or distribution and will not resell or otherwise transfer or dispose of the Company Shares except in accordance with the provisions of all Applicable Laws. |
| | | | 3.2 | | Company. The Company makes the representations and warranties set out hereto to the Sellers and Providence, recognizing that the Sellers and Providence are relying on such representations and warranties in entering into the transactions contemplated by this Agreement. All due diligence searches, investigations or inspections by the Sellers and Providence, up to the Closing Date, are without prejudice to the Sellers’ and Providence’s right to rely upon the representations and warranties of the Company in entering into the transactions contemplated by this Agreement. |
| 3.2.1 Incorporation and Qualification. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Texas and is duly qualified as a foreign corporation in all jurisdictions in which the failure to so qualify would have a material adverse effect on the Company. The Company has all requisite power and authority to own, lease and operate its respective properties. |
| 3.2.2 Authority, Filings, Consents and Approvals. The Company has the corporate power and authority to enter into this Agreement and to perform the transactions contemplated by this Agreement subject to shareholder approval and the filing of pertinent disclosure filings with the Securities and Exchange Commission (“Commission”). This Agreement has been duly authorized, executed and delivered by the Company’s board of directors and, subject to shareholder approval, constitutes a legal, valid and binding obligation of the Company, enforceable in accordance with its terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability relating to or affecting creditors’ rights and to general equity principles. Except for obtaining shareholder approval, no other proceedings on the part of the Company are necessary to authorize the consummation of the transactions contemplated hereby. The execution, delivery and performance of this Agreement and the agreements contemplated herein will not require the Company to obtain any other consent, waiver, authorization or approval of, or make any filing with or give prior notice to, any person, except for any such consents, waivers, authorizations or approvals which relate to shareholder approval and disclosure filings with the Commission. |
| 3.2.3 Capitalization of the Company. The authorized capital of the Company consists of fifty million (50,000,000) common shares par value $0.0001, of which seventeen million two hundred thirty thousand eight hundred forty-one (17,230,841) common shares are issued and outstanding and twenty five million (25,000,000) preferred share par value $0.0001, of which zero (0) preferred shares are issued and outstanding (the “Outstanding Shares”). The Outstanding Shares are duly authorized, validly issued, fully paid and non-assessable. |
3.2.4 Derivative Shares. The Company has the following derivative securities (the "Derivative Shares") issued and outstanding: | 3.2.4.1 three hundred and fifteen thousand one hundred and fourteen (315,114) common share purchase warrants exercisable at thirty cents ($0.30) per share at any time until November 30, 2010; |
46
| 3.2.4.2 four million four hundred and eighty one thousand dollars ($4,481,000) plus seven percent (7%) accrued interest in debt convertible into common shares at thirty five cents ($0.35) per share at any time until November 30, 2010; |
| 3.2.4.3 two hundred fifty thousand dollars ($250,000) plus ten percent (10%) accrued interest in debt convertible into common shares at twenty five cents ($0.10) per share at any time until May 6, 2010. |
| Except as to the Outstanding Shares and the Derivative Shares, the Company has not granted any other rights nor incurred any other commitments to purchase, acquire, convert or exchange any other securities for common or preferred shares of the Company and there are no other contracts, commitments, agreements, understandings, arrangements or restrictions that require the Company to issue, sell or deliver any of its stock or other securities. The Company has sufficient authorized, unissued shares of its common stock to consummate the transactions contemplated herein, and such stock bears no restriction on issuance that would prohibit issuance to the Sellers as contemplated herein. |
| 3.2.5 Corporate Records. All transactions of the Company have been promptly and properly recorded or filed in or with its respective books and records, and the minute books contain complete and accurate records of the meetings and proceedings of stockholders and directors thereof. |
3.2.6 Company Directors. The directors and officers of the Company are as follows:
Directors Officers
Nora Coccaro Nora Coccaro, President and Chief Executive
Officer,
Chief Financial Officer, and
Principal Accounting Officer
Markus Mueller
| 3.2.7 Liabilities. Except as shown in its most recent publicly released audited financial statements and interim un-audited financial statements (the “Company Financials”) the Company has no material liabilities of any kind whatsoever, contingent or non-contingent, other than those incurred in the ordinary course of business, including, without limitation, commercial real estate leases, utilities, telephone, and legal services. |
| 3.2.8 Liabilities at Closing. Except as may otherwise be set forth in Section 3.2.7 above, the value of all liabilities of the Company, including any exposure under any guarantees, as at the Closing Date, shall not be in excess of those normally incurred and paid by the Company in the ordinary course of business. |
| 3.2.9 Assets. The Company has good and marketable, legal and beneficial title to all of the property comprising its assets as shown on the Company Financials, free and clear of all Encumbrances. Such assets constitute all of the property, rights and other assets used by the Company, or which are necessary or desirable to conduct the Company’s business as conducted prior to the date hereof. Without limiting the generality of the foregoing, none of the personal property or the fixed plant and equipment shown in the company Financials is leased or otherwise used in the Company’s business subject to any agreement with any third party. |
47
| 3.2.10 Corporate Records and Financial Statements. All material transactions relating to the Company’s business have been promptly and properly recorded or filed in or with the Company’s books and records. The minute books of the Company contain complete and accurate records of the meetings and proceedings of stockholders and directors thereof. The Company Financials for the period ending March 31, 2006, fairly and accurately present the financial condition of the Company as at such date and the results of its operations for the period then ended. |
| 3.2.11 Environmental Compliance. Except in compliance with Environmental Laws, to the knowledge of the Company and its directors, the Company has not caused or permitted, and the Company and its directors have no knowledge of, any material release or disposal by any person of any Hazardous Substance on or from any premises formerly or presently used in the Company’s business. All Hazardous Substances generated, handled, stored, treated, processed, transported or disposed of in the course of the Company’s business have been generated, handled, stored, treated, processed, transported or disposed of in all material respects, in compliance with applicable Environmental Laws. |
| 3.2.12 Payment of Taxes. The Company has paid all Taxes due and payable in relation to the Company’s business and has paid all assessments that the Company has received in respect of Taxes. |
| 3.2.13 Reassessments. No reassessments of Taxes have been issued against the Company in relation to the Company’s Business nor is the Company aware of any pending or threatened assessment or reassessment for Taxes. The Company has not executed or filed with any Governmental Authority any agreement extending the period for assessment, reassessment or collection of any Taxes. |
| 3.2.14 Withholdings. The Company has withheld from each payment made to any of its current or former employees, officers and directors, and to all other persons, all amounts required by law and will continue to do so until the Closing Date. The Company has remitted or will remit, such withheld amounts within the prescribed periods to the appropriate Governmental Authority. The Company has charged and collected and has remitted or will remit on a timely basis all Taxes as required by Applicable Law on any sale, supply or delivery whatsoever, made in relation to the Company’s business. |
| 3.2.15 Contracts. The Company is not a party to, or bound by, any material contract, agreement or commitment of any kind in relation to its business other than this Agreement and the Note Exchange Agreement (the “Company Contracts”). The Company Contracts are in full force and effect. |
| 3.2.16 Employees. Complete and accurate particulars of the Company’s employees pertaining to the date of hire of such employees and their annual remuneration and the names of those on long term disability, workers’ compensation or leave of absence (if any) will be provided to Providence upon request. The Company does not have any written employment agreements relating to any of its employees. |
48
| 3.2.17 Collective/Employment Agreements. None of the Company’s employees is employed under a contract that cannot be terminated by the Company, with or without notice, including those employees who are employed on indefinite hire requiring reasonable notice of termination by Applicable Law. The Company is not a party, either directly or by operation of law, to any collective bargaining agreement. No trade union, council of trade unions, employee bargaining agency or affiliated bargaining agent holds bargaining rights with respect to any of the Company’s employees by way of certification, interim certification, voluntary recognition, or successor rights. There are no threatened or pending union organizing activities involving the Company’s employees and there are no threatened labor disputes or work stoppages relating to, or connected with, the Company’s business. |
| 3.2.18 Occupational Health and Safety. There are no outstanding inspection orders or charges or any other Orders made against the Company or its business. The Company is in compliance with all occupational health and safety rules and regulations in all material respects in relation to its business and there are no outstanding violations of such rules and regulations. |
3.2.19 Insurance. The Company carries no insurance related to its business or assets. | 3.2.20 Permits. The Company is in possession of and is in compliance with all Permits required by any Governmental Authority that are necessary to conduct the Company’s business. |
| 3.2.21 Absence of Legal Conflict. The execution and delivery of this Agreement by the Company does not, and the performance of this Agreement by the Company and the consummation by it of the transactions contemplated by this Agreement will not: |
3.2.21.1 conflict with or violate the constituent documents of the Company; 3.2.21.2 conflict with or violate any Applicable Law; or | 3.2.21.3 result in any breach of or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any note, bond, mortgage, indenture, contract, agreement, lease, license, permit, franchise or other instrument or obligation to which the Company is a party or by which the Company or any of its properties is bound or affected, which, in any such case, would prohibit or delay the Company’s ability to perform its obligations under this Agreement. |
| 3.2.22 Reporting Status. The Company is subject to the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, and is current in all required filings with the Commission as of the execution of this Agreement. The Company’s reports filed with the Commission can be viewed at www.sec.gov. The Company will obtain approval of the transactions contemplated herein by the shareholders of the Company pursuant to a proxy solicitation (the “Proxy Solicitation”). Without limiting the generality of the foregoing: |
3.2.22.1 the Proxy Solicitation will be conducted in compliance with Applicable Law. | 3.2.22.2 the meeting of the Company’s shareholders to approve the transactions contemplated in this Agreement (the “Meeting”) will be noticed and conducted in all material respects in compliance with Applicable Law and with the Company’s constituent documents. |
49
| 3.2.22.3 at the Meeting, a quorum of shareholders of the Company will be present in person or represented by proxy. |
| 3.4.22.4 the transactions contemplated in this Agreement will be presented to the requisite number of the Company’s shareholders present in person or represented by proxy at the Meeting, in accordance with Applicable Law and the Company’s constituent documents. |
| 3.2.23 Litigation. There are no claims, actions, proceedings, suits, investigations or reviews pending or, to the knowledge of the Company’s directors, threatened against the Company or otherwise in relation to the Company or its assets or the Outstanding Shares or the Derivative Shares, before or by any Governmental Authority or court. |
3.2.24 Conduct of Business - Changes. Since March 31, 2006: 3.2.24.1 the Company has conducted its business in the ordinary course, using reasonable efforts to preserve such business; 3.2.24.2 there has not been any material adverse change in the Company's assets, affairs or financial condition of the Company's business; 3.2.24.3 the Company has not: | 3.2.24.3.1 increased the compensation paid or payable to any of its employees or increased the benefits to which its employees are entitled or provided any new benefits for any such employees; or |
| 3.2.24.3.2 modified, amended or terminated any contract to which it is or was a party in relation to the Company’s business, except in the ordinary course of business with a view to the best interests of the Company’s business. |
| 3.2.25 Copies of Documents etc. True and complete copies of the documents and agreements listed in the Exhibits and Schedules hereto have been made available to Providence and its counsel for review. |
| 3.2.26 Investment Intent. The Company is acquiring the Providence Units for investment purposes only and not with a view to or for resale or distribution and will not resell or otherwise transfer or dispose of the Providence Units except in accordance with the provisions of all Applicable Laws. |
ARTICLE IV
CLOSING
4.1 Sellers' and Providence's Deliveries at Closing. On the Closing Date or unless expressly determined in writing otherwise, the Sellers and Providence shall deliver to the Company the following: 4.1.1 A Bill of Sale relating to the Providence Units, duly endorsed for transfer to the Company;
4.1.2 An original copy of a resolution of the sole manager of Providence authorizing the execution and delivery of this Agreement; 4.1.3 Any consents required to transfer the Providence Units to the Company;50
| 4.1.4 All discharges and notices of discharge, estoppel letters, pay-out letters or similar discharging documentation, in registrable form if required, which are necessary or desirable to effect or evince the discharge of any Encumbrances other than Permitted Encumbrances, all of which are satisfactory in form and content to the Company, acting reasonably; |
| 4.1.5 A closing certificate jointly signed by the Sellers and the principal officer of Providence, certifying that at and as of the Closing Date, the representations and warranties made by Providence and the Sellers contained in this Agreement are true and correct as if made at the Closing Date and that all covenants, agreements and conditions required by this Agreement to be performed or complied with by Providence or the Sellers prior to or at the Closing Date have been performed and complied with, except as otherwise specifically disclosed to Company by notice in writing; and |
| 4.1.6 Such other documents, certificates, instruments and agreements as are required or contemplated to be delivered to the Company by Providence or the Sellers pursuant to this Agreement. |
4.2 The Company's Deliveries at Closing. On the Closing Date or unless expressly determined in writing otherwise, the Company shall deliver to Providence and the Sellers the following: | | | | 4.2.1 | | Share certificates representing the Company Shares, duly issued for delivery to the respective unit holders of Providence as detailed in Exhibit D to this Agreement; |
| | | | 4.2.2 | | An original copy of a resolution of the board of directors of the Company authorizing the execution and delivery of this Agreement and the issuance of the Company Shares in exchange for the Providence Units; |
4.2.3 Any consents required to transfer the Company Shares to Providence; | 4.2.4 A closing certificate of a principal officer of the Company, certifying that at and as of the Closing Date, the representations and warranties made by the Company contained in this Agreement are true and correct as if made at the Closing Date and that all covenants, agreements and conditions required by this Agreement to be performed or complied with by the Company prior to or at the Closing Date have been performed and complied with, except as otherwise specifically disclosed to Providence and Sellers by notice in writing; and |
| 4.2.5 Such other documents, certificates, instruments and agreements as are required or contemplated to be delivered to Providence or the Sellers by the Company pursuant to this Agreement. |
ARTICLE V
CONDITIONS PRECEDENT TO CLOSING
| | | | 5.1 | | Conditions Precedent to Obligations of the Company. The obligations of the Company under this Agreement to consummate the Agreement contemplated hereby shall be subject to the satisfaction on or before the Closing Date, of the following conditions, provided, however, that the Company may waive the pre-Closing Date performance of the following conditions without waiving its right to require the post-Closing Date performance of the following conditions (unless expressly waived in a signed writing): |
51
| 5.1.1 Representations and Warranties True. The representations and warranties of Providence and of the Sellers shall be in all material respects true and accurate as of the date when made, and, except as to representations and warranties which are expressly limited to a state of facts existing at a time prior to the Closing Date, shall be in all material respects true and accurate at and as of the Closing Date. |
| 5.1.2 Performance of Covenants. Providence and the Sellers shall have performed and complied in all material respects with each and every covenant, agreement and condition required by this Agreement to be performed or complied with by each prior to or as of the Closing Date. |
| 5.1.3 No Governmental or Other Proceeding or Litigation. No Order of any court or administrative agency shall be in effect which restrains or prohibits any transaction contemplated hereby; and no suit, action, other than the exercise of dissenters’ rights, investigation, inquiry or proceeding by any governmental body or other person or entity shall be pending or threatened against Providence which challenges the validity or legality, or seeks to restrain the consummation, of the transactions contemplated hereby. |
| 5.1.4 Closing Documentation. The Company shall have received the documents identified in Section 4.1 and such additional documentation on the Closing Date as the Company and its counsel may reasonably require to evidence compliance by Providence and the Sellers with all of their obligations under this Agreement. |
| 5.1.5 Shareholder Approval. The transactions contemplated herein shall have been approved at the Meeting by holders of the requisite number of the Company’s outstanding voting securities. |
| 5.1.6 Note Exchange Agreement Executed, Consummated. The Note Exchange Agreement shall have been executed by all parties to it and the transactions contemplated therein shall have been consummated, or shall be consummated contemporaneously with the transactions contemplated in this Agreement. |
| | | | 5.2 | | Conditions Precedent to Obligations of Providence and the Sellers. The obligations of Providence and the Sellers under this Agreement to consummate the Agreement contemplated hereby shall be subject to the satisfaction, or to the waiver by Providence and the Sellers on or before the Closing Date of the following conditions, provided, however, that Providence or the Sellers may waive the pre-Closing Date performance of the following conditions without waiving their right to require the post-Closing Date performance of the following conditions (unless expressly waived in a signed writing): |
| 5.2.1 Representations and Warranties True. The representations and warranties of the Company shall be in all material respects true and accurate as of the date when made, and, except as to representations and warranties which are expressly limited to a state of facts existing at a time prior to the Closing Date, shall be in all material respects true and accurate at and as of the Closing Date. |
| 5.2.2 Performance of Covenants. The Company shall have performed and complied in all material respects with each and every covenant, agreement and condition required by this Agreement to be performed or complied with by it prior to or as of the Closing Date including but not limited to the obligation to loan Providence up to $5,000,000 pursuant to the terms of the Promissory Note on or prior to the Closing Date. |
52
| 5.2.3 No Governmental or Other Proceeding or Litigation. No Order of any court or administrative agency shall be in effect which restrains or prohibits any transaction contemplated hereby; and no suit, action, other than the exercise of dissenters’ rights, investigation, inquiry or proceeding by any governmental body or other person or entity shall be pending or threatened against the Company which challenges the validity or legality, or seeks to restrain the consummation, of the transactions contemplated hereby. |
| 5.2.4 Closing Documentation. Providence and the Sellers shall have received the documents identified in Section 4.2 and such additional documentation on the Closing Date as Providence and the Sellers and their respective counsel may reasonably require to evidence compliance by the Company with all of its obligations under this Agreement. |
| 5.2.5 Shareholder Approval. The transactions contemplated herein shall have been approved at the Meeting by holders of the requisite number of the Company’s outstanding voting securities. |
| 5.2.6 Note Exchange Agreement Executed, Consummated. The Note Exchange Agreement shall have been executed by all parties to it and the transactions contemplated therein shall have been consummated, or shall be consummated contemporaneously with the transactions contemplated in this Agreement. |
5.3 Special Consent. Providence acknowledges its understanding that the Notes are being assigned and transferred to the Company pursuant to the Note Exchange Agreement, and hereby expressly consents to such assignment and transfer.ARTICLE VI
INDEMNIFICATION
| | | | 6.1 | | Indemnity of Providence and the Sellers. The Company agrees to defend, indemnify and hold harmless Providence and the Sellers from and against, and to reimburse Providence and each Seller with respect to, all liabilities, losses, costs and expenses, including, without limitation, reasonable attorneys’ fees and disbursements (“Providence and Sellers’ Losses”), asserted against or incurred by Providence and such Sellers by reason of, arising out of, or in connection with any material breach of any representation or warranty contained in this Agreement made by the Company or in any document or closing certificate delivered by the Company pursuant to the provisions of this Agreement or in connection with the transactions contemplated thereby. Notwithstanding the foregoing provisions of this Section 6.1, no claim for indemnification shall be made by Providence or each Seller against the Company unless and until the aggregate of Providence and Sellers’ Losses shall exceed $25,000. |
| | | | 6.2 | | Indemnity of the Company. Providence and the Sellers, jointly and severally, agree to defend, indemnify and hold harmless the Company from and against, and to reimburse the Company with respect to, all liabilities, losses, costs and expenses, including, without limitation, reasonable attorneys’ fees and disbursements (“Company Losses”), asserted against or incurred the Company by reason of, arising out of, or in connection with any material breach of any representation or warranty contained in this Agreement and made by Providence or the Sellers or in any document or certificate delivered by Providence or the Sellers pursuant to the provisions of this Agreement or in connection with the transactions contemplated thereby; provided, however, that Providence and the Sellers shall only be required to defend, indemnify and hold harmless the Company for the representations and warranties made by Providence and the Sellers. Notwithstanding the foregoing provisions of this Section 6.2, no claim for indemnification shall be made by Company against Providence and the Sellers unless and until the aggregate Company Losses shall exceed $25,000. |
53
| | | | 6.3 | | Indemnification Procedure. A party (an “Indemnified Party”) seeking indemnification shall give prompt notice to the other party (the “Indemnifying Party”) of any claim for indemnification arising under this Article VI. The Indemnifying Party shall have the right to assume and to control the defense of any such claim with counsel reasonably acceptable to such Indemnified Party, at the Indemnifying Party’s own cost and expense, including the cost and expense of reasonable attorneys’ fees and disbursements in connection with such defense, in which event the Indemnifying Party shall not be obligated to pay the fees and disbursements of separate counsel for such in such action. In the event, however, that such Indemnified Party’s legal counsel shall determine that defenses may be available to such Indemnified Party that are different from or in addition to those available to the Indemnifying Party, in that there could reasonably be expected to be a conflict of interest if such Indemnifying Party and the Indemnified Party have common counsel in any such proceeding, or if the Indemnified Party has not assumed the defense of the action or proceedings, then such Indemnifying Party may employ separate counsel to represent or defend such Indemnified Party, and the Indemnifying Party shall pay the reasonable fees and disbursements of counsel for such Indemnified Party. No settlement of any such claim or payment in connection with any such settlement shall be made without the prior written consent of the Indemnifying Party which consent shall not be unreasonably withheld. |
ARTICLE VII
JOINT AND SEVERAL OBLIGATIONS
| | | | 7 | | The Sellers acknowledge and agree that the Company is entering into this Agreement in reliance upon the personal covenants of the Sellers and, accordingly, all covenants, representations and warranties provided by Providence in this Agreement are provided on a joint and several basis as between Providence and the Sellers with the intent and effect that Providence and the Sellers shall be jointly and severally bound thereby, and responsible therefor, up to the Closing Date, and after the Closing Date the Sellers shall remain jointly and severally liable for the breach of any representations, warranties or covenants under this Agreement made by any of Providence and the Sellers, and the Sellers will have no right of contribution from Providence in relation thereto. The Sellers agree with the Company that they shall perform, or cause Providence to perform, each and every covenant, agreement and obligation of Providence in this Agreement, and that Providence shall be bound by all such covenants, agreements and obligations as if it was providing such covenants and agreements, and assuming such obligations, personally. |
ARTICLE VIII
MISCELLANEOUS
| | | | 8.1 | | Amendment and Modification; Waiver. This Agreement may only be amended or modified in writing, signed by all of the parties hereto. No waiver in writing of any provision of this Agreement shall constitute a waiver of any other provision nor shall any waiver of any provision of this Agreement constitute a continuing waiver unless otherwise expressly provided. |
| | | | 8.2 | | Further Assurances. The parties will execute and deliver such further documents and do such further and other things as may be necessary to carry out and give effect to the intent of this Agreement and the transactions contemplated hereby. |
| | | | 8.3 | | Expenses. Except as otherwise expressly provided in this Agreement and whether or not the transactions contemplated by this Agreement are completed, the parties shall bear their own respective expenses (including, but not limited to, all compensation and expenses of counsel, consultants, actuaries and independent accountants) incurred in connection with this Agreement and the transactions contemplated hereby. |
54
| | | | 8.4 | | Public Disclosure. The parties agree that, except as may be required to comply with the requirements of Applicable Laws, the parties shall keep the terms of this Agreement, and the agreements entered into in relation hereto, confidential. In this regard, Providence and the Sellers acknowledge that the Company is a publicly traded and that the Company may decide, in its sole discretion, when and how to comply with applicable reporting requirements incumbent upon it’s publicly traded status. |
| | | | 8.5 | | Assignment. No party to this Agreement may assign any of its rights or obligations under this Agreement without the prior written consent of the other parties hereto, such consent not to be unreasonably withheld. |
| | | | 8.6 | | Parties in Interest. This Agreement shall enure to the benefit of and be binding upon the parties hereto and their respective successors, heirs or other personal legal representatives and permitted assigns. Except as expressly provided in this Agreement, nothing in this Agreement is intended to confer upon any person other than the Company, Providence and the Sellers or their respective successors, heirs or other personal legal representatives or permitted assigns, any rights or remedies under or by reason of this Agreement. |
| | | | 8.7 | | Counterparts. This Agreement and any amendments hereto may be executed in one or more counterparts, each of which shall be deemed to be an original by the parties executing such counterpart, but all of which shall be considered one and the same instrument. A signed facsimile or telecopied copy of this Agreement shall be effectual and valid proof of execution and delivery. |
| | | | 8.8 | | Performance on Holidays. If any action is required to be taken pursuant to this Agreement on or by a specified date which is not a Business Day, then such action shall be valid if taken on or by the next succeeding Business Day. |
| | | | 8.9 | | Notice. All communications, notices, requests, consents or demands given or required under this Agreement shall be in writing and shall be deemed to have been duly given when delivered to, or received by prepaid registered or certified mail or recognized overnight courier addressed to, or upon receipt of a facsimile sent to, the party for whom intended, as follows, or to such other address or facsimile number as may be furnished by such party by notice in the manner provided herein: |
If to Company:
Healthbridge, Inc.
1066 West Hastings Street, Suite 2610
Vancouver, British Columbia V6E 3X2
Attn: Nora Coccaro
Phone: (604) 602-1717
Fax: (604) 687-6755
Email: noracoccaro@attglobal.net
With a copy to:
Ruairidh W. Campbell, Esq.
Orsa & Company
1403 E 900 S
Salt Lake City, UT 84105
Phone: (801) 582-9606
Fax: (801) 582-9629
Email: ruairidhcampbell@msn.com
55
If to Providence: | Providence Exploration, LLC. 100 Crescent Court, 7th floor Dallas, Texas 75201 Attn: Abram Janz Phone: (214) 695-5848 Fax: (214) __________ Email: abrahamjanz@aol.com |
With a copy to:
David Turner, Esq.
Scheef & Stone, L.L.P.
5956 Sherry Lane, Suite 1400
Dallas, Texas 75225
Phone: (214) 706-4205
Fax: (214) 706-4242
Email:david.turner@solidcounsel.com
If to the Sellers:
Addresses for each Seller are detailed on the signature page hereto.
| | | | 8.10 | | Governing Law. This Agreement will be construed and enforced in accordance with and governed by the laws of the State of Texas, without reference to principles of conflicts of law. Each of the parties consents to the jurisdiction of the federal courts whose districts encompass any part of the State of Texas in connection with any dispute arising under this Agreement and hereby waives, to the maximum extent permitted by law, any objection, including any objection based on forum non conveniens, to the bringing of such proceeding in such jurisdictions. Each party hereby agrees that if another party to this Agreement obtains a judgment against it in such a proceeding, the party which obtained such judgment may enforce same by summary judgment in the courts of any country having jurisdiction over the party against whom such judgment was obtained, and each party hereby waives any defenses available to it under local law and agrees to the enforcement of such a judgment. Each party to this Agreement irrevocably consents to the service of process in any such proceeding by the mailing of copies thereof by registered or certified mail, postage prepaid, to such party at its address set forth herein. Nothing herein shall affect the right of any party to serve process in any other manner permitted by law. |
| | | | 8.11 | | Severability. If any provision of this Agreement is held to be invalid or unenforceable by a court of competent jurisdiction, this Agreement shall be interpreted and enforceable as if such provision were severed or limited, but only to the extent necessary to render such provision and this Agreement enforceable. |
| | | | 8.12 | | Entire Agreement. This Agreement, the Exhibits and any instruments and agreements to be executed pursuant to this Agreement, sets forth the entire understanding of the parties hereto with respect to its subject matter, merges and supersedes all prior and contemporaneous understandings with respect to its subject matter and may not be waived or modified, in whole or in part, except by a writing signed by each of the parties hereto. No waiver of any provision of this Agreement in any instance shall be deemed to be a waiver of the same or any other provision in any other instance. Failure of any party to enforce any provision of this Agreement shall not be construed as a waiver of its rights under such provision. |
[Signature Page Follows]
56
IN WITNESS WHEREOF each of the parties hereto has executed this Agreement as of the date first set forth above.
Company:
HEALTHBRIDGE, INC.
By: /s/ Nora Coccaro
Nora Coccaro Chief Executive Officer
Providence:
PROVIDENCE EXPLORATION, LLC
By: /s/ Abram Janz
Abram Janz
President
Sellers:
�� 100 Crescent Court, 7th floor
/s/ Abram Janz Dallas, Texas 75201
Abram Janz
100 Crescent Court, 7th floor
/s/ Shirley Janz Dallas, Texas 75201
Shirley Janz
57
EXHIBIT D
SELLERS
-------------------------------------------------------- ----------------
Seller No. Shares
-------------------------------------------------------- ----------------
-------------------------------------------------------- ----------------
Abram Janz 2,286,330
-------------------------------------------------------- ----------------
-------------------------------------------------------- ----------------
Shirley Janz 2,000,000
-------------------------------------------------------- ----------------
-------------------------------------------------------- ----------------
TOTAL 4,286,330
-------------------------------------------------------- ----------------
58
Note Exchange Agreement
BETWEEN
Healthbridge, Inc.
AND
Holders of Convertible Promissory Notes
Issued by Providence Exploration, LLC
DATED
April 10, 2006
59
NOTE EXCHANGE AGREEMENT
THIS NOTE EXCHANGE AGREEMENT (“Agreement”) is entered into as of April 10, 2006, by and between Healthbridge, Inc., a Texas corporation (“Company”), and the individuals and entities identified in Exhibit A to this Agreement (the “Holders”).
WITNESSETH:
WHEREAS, the Holders are the beneficial and record owners and holders of certain Convertible Promissory Notes (the “Notes”) issued by Providence Exploration, L.L.C., a Texas limited liability company (“Providence”);
WHEREAS, Providence has entered into a Joint Exploration Agreement with Harding Company, dated October 1, 2005, as amended, to purchase, explore and develop certain oil, gas and mineral interests underlying approximately 6,272 acres in Comanche and Hamilton Counties, Texas;
WHEREAS, Providence has entered into an Agreement of Purchase and Sale with Global Mineral Solutions, LP, dated March 31, 2006, to purchase, explore and develop certain oil, gas and mineral interests underlying approximately 12,832 acres in Val Verde County, Texas;
WHEREAS, the Company has entered into a commitment to loan up to five million dollars ($5,000,000) to Providence pursuant to a Secured Revolving Replacement Promissory Note, dated December 1, 2005, for the purpose of funding Providence’s purchase of said oil, gas and mineral interests and to fund Providence’s ongoing exploration and development obligations under said Joint Exploration Agreement and said Agreement of Purchase and Sale;
WHEREAS, contemporaneously with its execution of this Agreement the Company is entering into that certain Securities Exchange Agreement (the “Securities Exchange Agreement”) with Abram and Shirley Janz (collectively, “Janz”), sole members of Providence, pursuant to which Janz has agreed to exchange 100% ownership of Providence for certain shares of the $0.0001 par value common stock of the Company (“Company Stock”);
WHEREAS, the Company desires to acquire from the Holders, and the Holders desire to convey to the Company, all of the Notes in exchange for Twelve Million Two Hundred Thirteen Thousand Six Hundred Seventy (12,213,670) shares of Company Stock distributed to the Holders on a pro rata basis in proportion to their respective Note holdings on the Closing Date of this Agreement; and
WHEREAS, Janz has made it a condition to closing of the transactions contemplated in the Securities Exchange Agreement that the transactions contemplated in this Agreement be consummated; and the Holders have made it a condition to closing of the transactions contemplated in this Agreement that the transactions contemplated in the Securities Exchange Agreement be consummated.
NOW, THEREFORE, in consideration of the premises and of the mutual representations, warranties and agreements set forth herein, the parties hereto agree as follows:
60
ARTICLE I
DEFINITIONS AND INTERPRETATION
1.2 Defined Terms. Unless otherwise specifically defined in this Agreement or the context otherwise requires, capitalized terms used in this Agreement shall have the following meanings: | 1.1.1 “Agreement” means this agreement, the recitals hereto and the Exhibit attached to this Agreement, in each case, as they may be amended or supplemented from time to time, and the expressions “hereof”, “herein”, “hereto”, “hereunder”, “hereby”, and similar expressions, when used in this Agreement, refer to this Agreement as a whole and not to any particular provision of this Agreement; and unless otherwise indicated, references to sections and subsections are to sections and subsections in this Agreement. |
| 1.1.2 “Applicable Law” means any domestic or foreign statute, law, ordinance, regulation, by-law or order that applies to the Company, Providence, or the Holders. |
| | | | 1.1.5 | | “Assets” means all of the properties, rights and assets of Providence or the Company, as applicable, including, without limitation, Inventory, cash and cash equivalents, all investments, accounts receivable, drilling and service rigs, Goodwill, Lands, Fixed Plant and Equipment, Personal Property and material contracts. |
| 1.1.4 “Business” means the business of providing energy exploration services and the business of exploring, developing and producing oil and gas. |
| 1.1.5 “Business Day” means any day other than a Saturday, a Sunday or a day on which chartered banks in the United States of America are authorized or obligated by law to close. |
1.1.6 "Closing Date" has the meaning set forth in subsection 2.7. | 1.1.7 “Employees” means all persons engaged in the Business including employees, employees on leave, contract employees and owner-operators, if any. |
| 1.1.8 “Encumbrance” means any encumbrance of any kind whatever and includes, without limitation, any adverse claim, security interest, mortgage, lien, hypothecation, pledge, assignment, charge, trust or deemed trust (whether contractual, statutory or otherwise arising), or any other right, option or claim of others affecting the Assets, and any covenant or other agreement, restriction or limitation on the transfer of the Assets. |
| 1.1.9 “Environmental Laws” includes all applicable laws, statutes, regulations, by-laws, rules and Orders of any Governmental Authority where Providence has carried on business and the common law, relating, in whole or in part, to the environment, and includes those laws relating to the storage, generation, use, handling, manufacture, processing, transportation, import, export, treatment, release or disposal of any Hazardous Substance. |
| 1.1.10 “Environmental Permits” includes all certificates, approvals, consents, authorizations, registrations, and licenses issued, granted, conferred, created or required by any Governmental Authority pursuant to any Environmental Laws. |
1.1.11 “Fixed Plant and Equipment” means all plant, machinery and equipment situated on the Lands, if any.
61